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Abstract
Somatization, the presentation of physical symptoms without an identifiable
cause, is among the most common problems in primary medical care. Treatment
approaches are typically offered within the medical consultation interview once the
medical provider distinguishes between physical and emotional etiology. This
dualistic strategy is especially troublesome for patients whose physical complaints
cannot be validated and who are recommended for only mental health therapy. The
aim of this study was to examine how medical practitioners can instead motivate
patients to consider both physical and emotional treatment. An analogue intervention
consisting of an enhanced consultation interview was compared to a care as usual
consultation interview on the key outcome of motivation to engage in mental health
treatment. A total of 129 participants with medically unexplained symptoms were
randomly assigned to these two conditions. Motivation to engage in mental health
treatment was evaluated with the FMP Questionnaire, Credibility and Expectancy
Questionnaire, and the newly developed Motivation to Engage in Therapy
questionnaire (MET). Results of ANCOVA revealed significant differences between
the two analogue consultation interviews on 3 out of 5 outcome measures. The largest
effect was found for the MET followed by the credibility and expectancy subscales
(1.6, .9, and .8). This finding suggests that a particular type of discourse between
medical provider and patient can lead to increased motivation for holistic care
treatment for those with somatization.
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CHAPTER 1: INTRODUCTION
Somatization is the presentation of physical symptoms without an objective
and identifiable cause, and the condition is among the most common and challenging
problems in primary medical care (Bakal, Steiert, Coll & Schaefer, 2006). There has
been considerable examination of both etiology and treatment for somatization. In
spite of many advances, the condition continues to be plagued with uncertainty and
complexity. Somatization is beset by inherent problems of the dualistic practice
philosophy that operates in medicine and mental health. This perspective forces
symptoms to be reduced to fit into rigid pathological categories that are physical or
psychological (Salmon, Peters, & Stanley, 1999). The “either, or” approach invites
controversy especially when physical etiology is ruled out, leaving only a
psychological reason for the symptoms. Patients with a naïve understanding of
psychological influences might assume that symptoms are under their control and
could be overcome with will power (Kirmayer & Looper, 2006; Salmon, 2007).
Consequently, they may feel responsibility and blame. These feelings can be further
fueled when they are accused of having invalid or imagined symptoms (McFarlane,
Ellis, Fafoem, Barton, Browne, & Hoof, 2008).
When there is a dualistic explanation for the etiology of physical symptoms, a
contest between provider and patient is likely to ensue with patients attempting to
preserve their integrity and self-concept (Ring, Dowrick, Humphris, Davies, &
Salmon, 2005). Patients may try to accomplish this by fighting to prove that the
1

physician hasn’t looked hard enough and a diagnosis has yet to be established
(Salmon, 2007). Others “up the ante” by increasing the number or severity of
symptoms and still others may doctor shop until their physical problem is
substantiated (Dowrick, Ring, Humphris & Salmon, 2004). Even if skilled providers
acknowledge that the patient’s condition may be composed of both physical and
psychological problems, this information may often be communicated in a too late,
too little fashion, and after ruling out physical etiology. Patients may perceive the
explanation and subsequent recommendation as a last resort and feel abandoned or
dismissed (Peters, Stanley, Rose & Salmon, 1998). Regardless, the patient is left
with the burden of responsibility for symptoms that that cannot be labeled within the
current taxonomy. The weight of uncertainty, alone, is enough to evoke significant
stress (Nettleton, 2006).
Both patient and medical provider are influenced in their beliefs and
understanding of the evaluation and treatment for somatization through a societal
lens. Perspectives in the United States, for example, tend to endorse a dualistic
framework for treatment of many medical conditions. These perspectives tend to set
up a “no win” scenario for those with medically unexplained symptoms that fail to fit
neatly into a specific category. The dualistic paradigm calls for classifying symptoms
into mental or medical, eclipsing the notion of integrative care. Moreover, medical
provider and patient alike have been socialized to believe that physical care is
considered more credible and virtuous compared to mental health care, which
2

suggests weakness and deficiency. (Komiti, Judd, & Jackson, 2006; Lawrie, 2000).
The associated stigma attached to mental health care is still prominent and has been
shown to impede willingness to engage in psychological treatment (Kirmayer,
Groleau, Looper, & Dao, 2004). Together, bias toward physical care and stigma that
often accompanies mental health care converge to make assessment and treatment of
somatization a difficult undertaking. They are evident in practice, nosology, and
reimbursement policy (Komiti, Judd, & Jackson, 2006).
Creating a social standard for weaving together medical and psychological
care can help reduce stigma, be more effective and improve satisfaction for patient
and provider (Moran, 1999). Some encouraging hints of change suggest a shift in
societal views towards mental health care. For example, The Paul Wellstone Mental
Health and Addiction Equity Act, HR 1424, 2008) requires insurance plans to create
more parity between mental health and physical health care coverage. This law
ensures that an insurance company’s requirement for mental health reimbursement is
more equitable with health care reimbursement, in demand for co-payments and
deductibles as well as in limitations on visits and cap on lifetime dollar amount. This
legislation may be a cornerstone for transforming the societal view of dualistic care
with which our country has been so strongly tied.
Optimal outcomes for those who have been identified with somatization will
more likely be realized if attention to the psyche and body are approached and
treated simultaneously (Aiarzaguena, Grandes, Salazar, Gaminde, & Sanchez, 2008).
3

There has been recent support for this multifaceted approach (Looper & Kirmayer,
2002; Morriss, et al., 2006; Smith, et al., 2006). Yet, most patients are reluctant to
engage in psychological treatment (Arnold, Speckens, & van Hemert, 2004; Barsky,
& Ahern, 2004; Sumathipala, Hewege, Hanwella, & Mann, 2000). Thus far, these
approaches have not been able to fully determine methods that affect patients’
motivation to engage in therapy in concert with medical care. Those with
somatization are thought to be characteristically different in ways that make
discussion and compliance with mental health more challenging than other patients
who seek help from their primary care provider. And a central difference is their
firmly held belief that there is a somatic cause of their symptoms; thus, suggestions
of psychological sequelae or treatment can position the patient at odds with their
self-concept (Barsky & Borus, 1999). Any successful model of treatment will need
to address these and other crucial issues that affect patient motivation to engage in
mental health treatment. The physician is typically the gateway to formulating a
treatment plan for somatization, and he or she can use the patient-doctor consultation
process as the venue to enhance motivation of the patient with somatization to
engage in mental health treatment (Kravitz, 2001).
The focus of this dissertation is the identification of issues that could be
discussed by the physician during the consultation process that would motivate the
patient to engage in mental health therapy while maintaining a medical relationship.
A discussion of somatization’s history, definitions, prevalence, consequences and
4

importance to social work and policy is first presented. Chapter Two provides a
review of the literature on patient characteristics thought to contribute to
somatization, and treatment approaches, highlighting difficulties inherent in referring
patients to mental health treatment and how the consultation process between patient
and provider can impact motivation for therapy. Next, Chapter Three offers a
cognitive theory of motivation which informs and supports the study’s approach.
Chapter Four details the study's methodology and Chapter Five presents the results.
Chapter Six concludes with the findings, strengths and limitations of the study.
The Problem of Somatization
History
Somatization, a term first used by psychoanalyst, Wilhelm Stekel, in the early
1900’s, reflects physical symptoms with an underlying psychological conflict
(Marin, & Carron, 2002). Somatization has been recognized for centuries although
the terms used to define its nature and etiology have undergone many transitions.
These shifting meanings continue to exert influence on diagnosis and treatment. The
Egyptians were thought to be the first ones to examine medically unexplained
physical symptoms, but it was the Greeks, over 4,000 years ago, who first used the
word hysteria (Gilman, King, Porter, Rousseau, & Showalter, 1993) to describe a
host of unexplained physical ailments. Hysteria, which literally translates to
“womb”, was thought to arise from a physical etiology, affecting only females with
the womb as the source of pain. However, sometime during the 18th century, the
5

term hysteria was re-conceptualized as having a psychological etiology. Unexplained
physical symptoms were no longer understood to be associated with bodily
mechanisms but rather contrived and embellished with an emotional foundation. This
altered framing may have set in motion the “either/or” body or mind conundrum
evident in our diagnostic and classification system today. Hysteria has been used as
the dominant term to describe unexplained pain up until the early 1900’s, however
remnants of this earliest meaning can still be observed in the DSM-IV-TR (American
Psychiatric Association, 2000). An example is conversion hysteria, which had its
roots in the 19th century and was first advanced by Freud and Breuer. This concept
describes how underlying anxiety created by unconscious conflict is transformed into
a somatic symptom in order to protect an individual from overwhelming negative
emotions (Van der Hart, & Friedman, 1989). This characterization remains in the
DSM-IV-TR diagnostic classification as simply conversion disorder.
Interest in mind and body evolved out of two frameworks: psychosomatic
medicine and psychoanalysis (Taylor, 2002). These different yet overlapping camps
exerted influence on the understanding and interpretation of hysteria. The word
hysteria was not replaced at this time but was joined by another term
“psychosomatic”, which was coined in 1818 by Heinroth (Panconesi & Argentieri,
2000). The term “psychosomatic” contains the roots of psyche and soma, suggesting
that mind and body are distinct entities, however they act together to influence
physical symptoms. The idea that these concepts are separate yet related is addressed
6

through a psychoanalytic perspective offered by psychoanalyst, D. W. Winnicott. He
proposed that psychosomatic problems were a function of a weakened connection
between the body and mind which destabilizes the ego or causes a split in the
individual’s personality in defense of threat to the personality (Meissner, 2006). The
conceptual dance between monism and dualism continues to remain a polemic in
diagnosis and treatment.
In theory, the term psychosomatic seems to embrace the monistic position
regarding the mind and body by conveying the interdependence of both. However, in
application, especially with respect to treatment, psychosomatic is a dualistic
paradigm. Those with psychosomatic illness are examined by distinguishing what
symptoms arise from the body and what symptoms arise from the mind, thus treating
them as separate conditions. The popularity and interpretation of the term
“psychosomatic” peeked during the 1950’s, (Woolfolk & Allen, 2007) and faded
thereafter, but its pejorative meaning could be still be appreciated in the literature
and continued into the 21st century. A study by Stone, Colyer, Feltbower, Carson,
and Sharpe (2004) found that in 34% of the 477 newspapers articles they examined,
the use of psychosomatic was used to describe an imaginary or malingering illness.
The reductionistic framework created by separation of mind and body can be
a useful mechanism to understand medical pathology and apply treatment. For
example, if a patient presents with a fractured leg, it would be both understandable
and appropriate to provide direct assessment and treatment with physical care. Yet,
7

many conditions may be a complex web integrating many systems. Over the past
decade, an emerging field of study referred to as psychoneuroimmunology–the
complex interplay between behavior, brain and the immune system-- has been
gaining momentum. Once considered a fairly restricted and closed system, the
immune system is currently thought to interact in a bi-directional way with the brain
and behavior via chemical and electrical signals (Maier, Watkins and Fleshner,
1994). Therefore, problems with immunity cannot be simply explained nor treated in
purely physical way. Stressors can affect immune function through hormones and
autonomic activation, resulting in physical and psychological symptoms.
A good example of this process is depression. Depression can activate
autonomic outflow and release hormones which, in turn, impacts immunity.
Depressed individuals often have elevated levels of glucocorticoids in their blood
(Mitchell, & O'Keane, 1998; Ströhle, 2003). Glucocorticoids are naturally-produced
steroid hormones, or synthetic compounds that inhibit the process of inflammation.
The elevated levels are thought to be caused by impaired glucocorticoid receptor
feedback at the level of the hypothalamic-pituitary-adrenal (HPA) axis.
Glucocorticoids can act with depression and can negatively affect immunity response
through modulation of neural and hormonal factors. Conversely, lowered immune
function is associated with depression. Psychological processes such as behavior and
emotion can thereby influence the bi-directional network of immunity and brain and
be affected by it.
8

Another example of this complex interplay is fibromyaliga, a syndrome at the
forefront of the spirited debate between physical and psychological etiology.
Fibromyalgia is a condition that might very well have a physical etiology but,
because there are no objective diagnostic tests available, the weight of explanation
leans towards psychological orientation. There is developing evidence, however, that
disturbances or abnormalities in the neuroendocrine systems may be largely
responsible for fibromyalgia symptoms (Peterson, 2007). In particular, fibromyalgia
seems to be associated with abnormalities in glucocorticoid sensitivity.
Glucocorticoid receptor affinity is thought to lower hypothalamic–pituitary–adrenal
(HPA) axis resiliency (Macedoa, Hessec,Turnera, Meyerd, Hellhammerc, & Mullera,
2008).
Some also might argue that the dualistic approach to health care serves a
pragmatic function for managing structural differences in access to care (Kirmayer &
Young, 1998). In those societies where there is an implicit understanding that
treatment is afforded to those who present with physical symptoms versus
psychological symptoms, the presentation of somatization can be understood as a
practical approach to access care. However, this argument doesn’t fully explain the
expression, interpretation and treatment of somatization.
Culture also may play a large part in how symptoms are expressed. Although
research has documented that somatization is ubiquitous and found in countries
around the world, not all require the distinction between physical and psychological
9

symptoms in order for individuals to receive care (Keyes, & Ryff, 2003). Viewing
physical or psychological symptoms as a cultural construction provides a slightly
different conceptualization of somatization (Kirmayer & Young, 1998). This
framework suggests that somatization can’t be separated from the socio-cultural
experience in which the individual is situated. Ethnographic expressions of distress
come to bear on the understanding, presentation and interpretation of somatization.
Often physical symptoms coexist with emotional stress, if not underlying it. These
observations are apparent in ethnocultural groups regardless of access to health care.
For example, the Korean “syndrome” hwa-byung is characterized by physical
symptoms such as heaviness, burning muscular aches, dry mouth, insomnia, and
indigestion—all of which are understood and attributed to suppressed rage (Pang,
1990). There is more than a tacit understanding that symptoms of this syndrome are
interwoven with suppressed feelings of anger and resentment that contribute to pain
in the chest. Individuals with hwa-byung readily associate emotional stress with
manifestations of physical symptoms. The extent to which these symptoms are
embedded in social and cultural processes reveal and support discourse consistent
with the expression of physical symptoms, suffering and treatment. Interestingly,
these syndromes lie outside our current nosology. In the DSM-IV-TR they are listed
in a separate section, which seems to imply acceptance of both physical and
psychological presentation and treatment without establishing pathology for one or
the other.
10

It is difficult to imagine a presenting medical condition in which assessment
and treatment might be improved if both brain and behavior (mind and body) were
considered. As medicine is evolving with the onset of newer disciplines such as
psychoneuroimmunology and psychoneuroendocrinology, the chasm between mind
and body is further being challenged and possibly narrowing (Woolfolk & Allen,
2007). Nevertheless, there still seems to be more acceptance of mixed etiology for
medically presented symptoms in contemporary medicine. Acceptance of mixed
treatment is less well established (Dimsdale, & Dantzer, 2007).
It is important to acknowledge that just as the dualistic view can be observed
as reductionistic, so too can the monistic approach which suggests that both physical
and psychological symptoms co-exist with the equal magnitude. It has been
suggested that the influence of either physical or psychological attribution lie on a
continuum with one or the other exerting different degrees of influence at any one
time (Aiarzaguena, et al., 2008). This fluid relationship offers a more flexible and
wider view from which to diagnose and treat somatization. Embracing this
perspective that both physical and psychological factors can weigh in at different
degrees and different times, eclipses the need to diagnose and label symptoms as
purely one or the other. Treatment of symptoms with an integrated holistic approach
will be most effective, irrespective of etiology.
How medical providers perceive and subsequently offer treatment options for
somatization largely depends on their respective ideological stance towards
11

symptoms and disease, which also is embedded in socio-cultural values (Kirmayer,
Groleau, Looper, & Dao, 2004). In the Western world, medical providers might not
fully appreciate cultural underpinnings that influence presentation and treatment of
symptoms. Social workers on the other hand—by virtue of their education-- have a
fundamental understanding of the impact of social and cultural influences on
behavior. With additional training, social workers can play a key role in raising
awareness in medical providers.
Current Definitions
Somatization (formerly known as Briquet’s Syndrome (Guze & Perley, 1963)
made its way into one of the diagnostic classifications in the DSM III and is
currently one of the most common terms used to describe the development and
persistence of physical problems for which there is no organic basis that can be
objectively tested or demonstrated (Keyes & Ryff, 2003; Oyama, Paltoo &
Greengold, 2007). Medically unexplained symptoms (MUS) is another term
observed in the literature, often used interchangeably with somatization. MUS
terminology has been criticized for presupposing that no explanation for symptoms
exist (Brown, 2007). However, this term remains neutral towards any dualistic
expression. Unfortunately the use of different terminology has perpetuated the debate
of mind vs. body with no term to date accepted as adequately portraying the
condition. Essentially these terms force providers to make a differential diagnosis
primarily through exclusion of symptoms that can be physical or psychological.
12

While the controversy over classification criteria continues, a term that provides
common ground provides a solution. The term selected for this study was
“somatization” for two reasons: it fits with the nomenclature more commonly
understood by mental health professionals and the focus of the study was
identification of strategies to engage patients in mental health therapy.
There is some disagreement about the diagnostic criteria for somatization.
The DSM-IV-TR classification for Somatization Disorder requires onset before age
30, symptoms which last for several years, including at least four unexplained pain
symptoms, two unexplained non pain gastrointestinal symptoms, one sexual or
menstrual symptom and one pseudoneurological symptom (American Psychiatric
Association, 2000). The International Statistical Classification of Diseases and
Related Health Problems (ICD-10) requires a history of six unexplained symptoms
from which two must be from gastrointestinal, cardiovascular, genitourinary, and
skin pain (World Health Organization, 1993). These criteria have been relaxed with
most studies (e.g., Feder, et al., 2001; Hiller, Rief, & Brahler, 2006) using the
abridged somatization disorder (sometimes referred to as “subthreshold
somatization”). This construct of somatization was developed by Escobar, RubioStipec, Canino, & Karno (1989) and requires six unexplained physical symptoms for
females and four for males; one of which has been present within the last year. Often
the diagnosis is determined by ruling out organic etiology (De Gucht & Maes, 2006).
The DSM-IV-TR and ICD-10 also include diagnostic categories for somatization. In
13

the DSM-IV-TR, undifferentiated somatoform disorder is defined as one or more
physically unexplained symptoms lasting for 6 months and the ICD-10 requires
multiple unexplained physical symptoms lasting for six months (Woolfolk & Allen,
2007). Moreover, the term somatization has extended beyond symptoms to
syndromes such as chronic fatigue, fibromyalgia and irritable bowel. Although these
classifications can present difficulty in understanding and synthesizing the research,
the interpretations share a common thread; a chronic physical complaint that cannot
be adequately explained by physical findings and for which the application of both
mental and physical treatment is essential (De Gucht & Fischler, 2002; Woolfolk &
Allen, 2007).
Prevalence
The prevalence rates of somatization also present some challenges as they are
subject to differences in type of setting, measure and time (e.g., year vs. lifetime)
(Gureje & Simon 1999; Hiller, Rief, & Brahler, 2006). Rates also vary depending on
whether they were estimated for somatization, somatoform or the abridged definition
of somatization used by Escobar, et al. (1989), the ICD-10 or DSM-IV-TR. For
somatization disorder, the strictest diagnostic criteria of the ICD-10 or DSM-IV-TR,
which includes multiple complaints from different and specified organs, the
prevalence of somatization is actually quite low—around 1% to 5% both in the
general population and in primary care (Escobar, Gara, Silver, et al., 1998; Fink,
Sorrenson, Engberg, Holm, Munk-Jorgensen, 1999; Katon & Walker, 1998).
14

Prevalence estimates for somatoform in primary care, a broader classification within
the ICD-10 or DSM-IV ranges between 15% to 30% (Kroenke, 2003; Kirmayer,
Groleau, Looper, & Dao, 2004). For the abridged definition of somatization in
primary care, the range of prevalence rates are from 19% to 22% (Escobar, RubioStipec, Canino, & Karno, 1989; Escobar, Waitzkin, & Cohen, 1998; Escobar,
Waitzkin, Silver, Gara, & Holman, 1998; Gureje, Simon, Ustun, & Goldberg, 1997;
Kirmayer & Robbins,1991).
Prevalence rates that distinguish age categories also have been studied. Using
the DSM-IV classification, Fink et al. (1999) found estimates for prevalence as high
as 30% for those between 18 and 65. Others also using the same classification
distinguished between age groups. De Waal, Eckhof, & van Hemert (2004) found
differences in prevalence of somatization for the following age categories: 22% for
those ages between 25 and 45; 15% for those ages between 45 and 65 and 5% for
those ages between 65 and 79.
Regardless of the criteria used for somatization, women appear to be at
higher risk than men (Leiknes, Finset, Moum, & Sandanger, 2007; Woolworth &
Allen, 2007). There also is evidence that somatization is prevalent in many countries
around the world, although there are differences in prevalence (Kisely & Simon,
2006), with Latin America having the highest level (Gureje, Simon, Ustun &
Goldberg, 1997).

15

Public Health Relevance
Consequences
Several studies have documented negative consequences for unexplained
somatic complaints, such as emotional and physical suffering as well as increased
use of health resources (Katon et al., 1991; Shaw & Creed, 1991). In particular, those
with somatization suffer marginalization and stigmatization (Ring, et al, 2005), and
disability (Escobar et al., 1987; Simon & VonKorff, 1991). These individuals also
are at risk of iatrogenic harm (physician induced harm by words or therapy),
especially during the course of ruling out physical etiology (Ring, et al., 2005;
Rosendal, Olesen & Fink, 2005; Salmon, Ring, Dowrick, & Humphris, 2005).
Unexplained physical symptoms can lead to extensive, intrusive and less appropriate
tests (Katon et al., 1991; Oyama, Paltoo & Greengold,. 2007; Salmon, et al., 2005;
Smith, Monson & Ray, 1986) and even surgery (Salmon, 2007).
The devastating consequences of somatization are palpable for increased
health care costs. In a study by Smith, Monson and Ray (1986), patients with
somatization were shown to incur health care related expenses 9 times higher than
the average costs of health care per capita in the US. A controlled study conducted
by Hiller, Fichter, and Rief (2003) demonstrated that those patients with somatoform
disorders were found to have a 2.2 fold higher than average inpatient and outpatient
health care costs in a two year period prior to receiving cognitive-behavioral
treatment. After treatment, noteworthy savings in health care costs were realized;
16

24.5% for outpatient care and 36.7% for inpatient care. These costs were found to be
independent of comorbid mood and anxiety disorders as well as medical illness. A
more recent study of approximately 2000 patients measured medical care utilization
and costs in two hospital-affiliated primary care practices (Barsky, Orav & Bates,
2005). Even after adjusting for anxiety and depressive disorders, those with
somatization had more hospital admissions, inpatient costs, emergency room visits,
primary care visits, and specialist visits, compared to those without the diagnosis.
Importance for Social Work
Social work has a long tradition of providing mental health treatment.
According to the NASW Behavioral Health Practice Update (October, 2003),
approximately 50% of social workers are employed in mental health. The social
worker’s biopsychosocial orientation provides a strategic advantage for addressing
individuals with somatization from a holistic perspective, regardless of setting. With
this background and training, a social worker can be an ideal member of a health
care team that can provide the mental health treatment component for those with
somatization, whether in the hospital or primary clinic. Looper and Kirmayer (2002)
support having both medical and psychological services under one roof. This
approach conveys a supportive message for integrative treatment and further reduces
barriers for patient’s motivation to engage in mental health treatment. Models of care
which comprise a physician and social work team have been introduced and piloted
in sites around the country (The Permanente Journal, 1998), with promising
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opportunities for social workers to bring their biopsychosocial perspective to patients
with somatization.
There are a few potential obstacles for social workers to overcome in
supporting individuals with somatization. Social workers may not always be the first
resource considered for addressing the mental health issues facing those with
somatization. Social work’s presence in the medical arena has been traditionally
limited to the impatient care setting (McGuire, Bikson, & Blue-Howells, 2005).
Social workers used in primary care clinics are rare. Perhaps their absence in this
setting reinforces the perception by providers and patients alike that social workers
are ill equipped to address complex and holistic problems such as somatization
(Lesser, 2000). Social workers are often relegated to the tasks of discharge planning
rather than looked upon as a formidable discipline with mental health expertise and
equal credibility with the medical provider (Cowles, & Lefcowitz, 1995). Social
workers often compete with nurses and other disciplines such as psychology for
counseling referrals (Smith, et al., 2003).
Social work, equipped with its biopsychosocial framework, can serve as the
lens through which somatization is viewed. This function can help broaden
understanding of the various interpretive stances of somatic symptoms that reside in
both provider and patients. Regardless of whether symptoms might be the expression
of as actual perturbations in physiology, metaphor for psychological conflict,
psychogenic pathology; social-economic, cultural, or some other idiom of distress
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(Kirmayer & Young, 1998), social workers can help medical providers and patients
move towards holistic care. Social workers can promote appreciation of, and
empathy for, medical providers whose efforts may be thwarted by the duality of
medicine-- its categorical and inflexible prescription for treatment options. So too
can social workers honor the ideological stance of patients for whom help with
suffering is not predicated on the distinction between physical and psychological but
rather the acknowledgement of their experience. Findings from the current study
support how social workers can help guide medical practitioners and patients toward
integrative treatment and optimal care.

Potential Benefits of Integrative Care Approach for Policy and Training
Integrative treatment planning needs to be considered in the formulas for
medical and mental health reimbursement. The medical provider’s initial discussions
with patients as well as ongoing collaboration with mental health providers are
valuable services that promote comprehensive health care and deserve remuneration.
The introduction of managed care can be viewed as an important mechanism to
evaluate and monitor as well as to curtail health care’s skyrocketing costs (Moran,
1999). Although managed care’s vigilance for cost control can be appreciated, its
success in curbing financial expenditures was accomplished, in part, by taking a
disproportionately harder line toward mental health care, compared to physical care.
This approach results in forfeiting integration of physical and mental health care
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which, in turn, promotes dualistic care and reinforces stigma around psychological
treatment. It seems timely for a costs saving strategy alteration. Studies have shown
that integrative care can improve provider and patient care satisfaction (Kirmayer,
Froleau, Looper, & Dao, 2004). It can also improve patient outcomes of reduced
symptoms and severity, as well as decrease costs. A meta-analysis conducted by
Chiles, Lambert and Hatch (1999) demonstrated that psychological interventions can
impact medical costs across various medical and psychological settings.
Psychological interventions were characterized as either psychotherapy (consisting
of crisis intervention, short-term psychotherapy, relaxation training and group
therapy) or psychoeducation (behavioral medicine pre-post procedural instruction
geared toward anxiety reduction and management of expectations, and biofeedback.
While there was a significant effect for both types of interventions, psychoeducation
outperformed psychotherapy in outpatient settings with a larger effect (.52 vs. .21).
However, this finding is not surprising since psychotherapy is time limited in most
settings such as hospitals, and physical health is often an indirect focus in mental
health settings. When evaluating costs saving for medical care in outpatient
counseling settings, it is difficult to identify costs offsets for medical conditions as
these are not usually specified as the reason or focus of the treatment. Nonetheless,
regardless of how counseling is characterized, there are significant advantages to the
patient and health care costs with psychotherapeutic and psychoeducation
interventions.
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While there are a few medical specialties— aging, chemical dependency and
rehabilitative medicine-- that have already adopted the physical and mental health
team approach, there remain other specialties besides primary care that remain
embedded in dualistic practice. Among these, for example, are cardiology,
neurology, and gynecology. Many outpatient clinics could also benefit from a joint
perspective and integrative model for patient care.
If social work is to become an integral player on the medical team to address
somatization, it will likely require acquisition of new skills or refinement of old ones.
These skills may include comprehensive knowledge of somatization—how it is
diagnosed, its diverse presentations, elements of optimal care; the prevailing cultural
stigma of psychotherapy; and the theoretical and logistic barriers related to patient’s
motivation for integrative treatment. This could be accomplished in schools of social
work or other venues. Similarly, using integrative intervention models may pose new
challenges for medical care providers who also will need additional training. This
training could be integrated into teaching hospitals for medical practitioners. It is
conceivable that combined teaching efforts for medical and mental health
professionals might afford the best strategy to obtain the requisite knowledge to
manage the intricacies involved in helping and caring for this population.
Summary
Somatization is a multifaceted and persistent problem. It has been defined
through a series of shifting perspectives beginning in the 18th century, which have
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yielded both informed and ambiguous understandings of this condition. Yet, there
seems little doubt that the problem is prevalent and its consequences severe. Mental
health therapy in addition to medical care is integral to the successful treatment for
those with somatization (Deary, Chalder & Sharpe, 2007). Society plays a central
role in shaping the particular orientation to health care that guides how both patients
and medical providers alike expect to evaluate and treat patients with medically
unexplained physical symptoms (Kirmayer & Looper, 2006). Patient and provider
biases towards dualism coupled with the stigma around psychological care can result
in patient’s tightened grip on beliefs about the physical nature of their symptoms and
corresponding physical treatment. Although society is slowly embracing some of the
aspects of integrated care (e.g., new legislation), it has a ways to go before integrated
care is truly accepted. Until then, patients and providers will most likely forfeit
psychological care and defer to medical treatment to ameliorate suffering for those
with somatization even though this practice may result in outcomes that are
unacceptable to both patient and provider.
Recommendation for integrative treatment must make explicit that the role of
mental health therapy will be to help with the management of symptoms (regardless
of the etiology), which negates implications that the patient’s symptoms are all in
their head. Mental health therapy can specifically attend to the distress known to be
associated with an unexplained diagnosis (Rhodes, McPhillips-Tangum, Markham,
& Klenk 1999). Social work is in a unique position to provide mental health
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treatment to these patients. Findings from the present study inform medical providers
in methods for engaging patients in therapy as well as enhancing social worker’s
development of additional collaborative skills.
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CHAPTER 2: LITERATURE REVIEW
The literature highlights those characteristics thought to put individuals at
risk for development of somatization as well as those characteristics that affect
treatment of this condition. It should be noted, however, that much of the literature
and associated research have been conceptualized from dualistic rather than
integrative perspectives. As such, patient factors, in contrast to medical practitioner
factors, are given greater emphasis, which may unfairly underscore patient
accountability. Additionally, most of the studies conducted derive their findings from
correlational data which precludes understanding of cause and effect. Therefore,
based on existing research, it is difficult to determine precisely which causal factors
actually impact somatization. Nevertheless characteristics shown to be associated
with somatization bear mention and include childhood experience of illness in
parents and parent’s experience with illness behavior, PTSD, personality traits,
attributions, expectations, depression, health anxiety and worry, and sensitization.
(See Figure 1).
Characteristics Affecting Somatization
Parental Illness.
Hotopf, Mayou, Wadsworth, and Wessely (1999) found that children with
unexplained medical symptoms or children with a family member who had
unexplained medical symptoms were more likely to develop somatization later in
life, compared to those children without a personal or family history of somatization.
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Similarly, Craig, Cox and Klein (2002) found that adults with somatization were
more likely to report that as children they had a parent or other family member with
a physical illness, compared to adults who were not diagnosed with somatization.
Additionally, a study by Hotopf, Wilson-Jones, Mayou, Wadsworth, and Wessely
(2000) revealed that there was a strong risk factor for somatization in those children
with fathers who identified their health as poor.
Posttraumatic Stress Disorder (PTSD).
There has also been a compelling line of evidence that demonstrates an
association between PTSD and unexplained physical symptoms ( Andreski, Chilcoat,
& Breslau, 1998; Escalona, Achilles, Waitzkin, & Yager, 2004; Gillock, Zayfer,
Hegel, & Ferguson, 2005; Leserman, 2005). For example, Andreski, et al.(1998)
demonstrated with a HMO sample of 1000 patients that those with PTSD were more
likely to express somatic symptoms than any other disorder. Escalona et al., 2004
found that, after controlling for mood and anxiety disorders, posttraumatic stress was
one of the strongest predictors of somatization. In particular, numbing was found to
be the most robust feature of PTSD associated with somatization. The association
between PTSD and medically unexplained physical symptoms is particularly strong
for women (Gill, Szanton, & Page, 2005). Moreover, PTSD for women has
frequently been linked to early adverse life experiences such as child abuse (Spertus,
Yehuda, Wong, Halligan, & Seremetis, 2003). These adverse childhood experiences
have, in turn, been demonstrated to affect the development and course of
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somatization in adulthood (Stuart & Noyes, 1999). PTSD is currently being
considered central to understanding how fear and avoidance may underlie chronic
pain pathology. PTSD is considered to affect memory and attention, which result in
alternate and perhaps inaccurate processing and interpreting of information
(McFarlane, et al., 2008).
Personality Traits.
Personality traits also have been considered to be a factor in somatization.
There appears to be evidence to suggest that somatization is correlated with higher
incidence of personality disorders, in general (Noyes, et al., 2001) and neuroticism,
in particular. However, others have shown associations between somatization and
schizotypal, obsessive–compulsive and paranoid personality disorders. The
behavioral patterns related to personality disorders can have an impact on the
medical consultation. Patients with personality disorders can feel misunderstood,
disrespected, and pessimistic in this context. Consequently, these negative
interactions between patient and medical provider interfere with treatment planning
and ultimately symptom improvement (Vandenbergen, Vanheule, Rosseel, Desment
& Verhaeghe, 2009).
Negative affectivity is a stable personality trait that has been measured by
various scales and referred to as neuroticism, maladjustment and trait anxiety
(Watson & Pennebaker 1989). This negative affectivity dimension is characterized
by negative mood, general dissatisfaction, distress and negative self-concept. Watson
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and Pennebaker found that while there is a strong association between negative
affectivity and health complaints, negative affectivity failed to predict long-term
health outcomes. Rather, those who had negative affectivity may have a
predisposition to be vulnerable to somatization. Noyes, et al., (2001) also found that
negative reactivity was related to those with somatization. Additionally, Noyes and
his colleagues found that scores for neuroticism and lower agreeableness were higher
for those with somatization than for controls. In a review by Deary, et al., (2007),
neuroticism was found to be associated with elevated response to stress, and
increased vulnerability to physical illnesses, as well as being correlated with
heightened attention to potential indications or cues of physical pain.
Causal Attributions.
Causal attribution is a construct defined as the interpretation and assignment
of a cause to a problem (Weiner, 1986). It is important because the act of
interpretation and explanation of a cause will most likely lead to a particular
cognitive and behavioral response. The attributed cause can be positive or negative,
controllable or uncontrollable, internal or external, stable or unstable (this reflects the
extent to which a cause can change), physical or psychological.
The concept of causal attribution has made considerable contributions to the
literature on a number of social phenomena such as depression, responsibility
judgments, well-being and motivation (Jones, Kanouse, Kelley, Nisbett, Valins, &
Weiner, 1974; Weiner, 1995; Abramson, Seligman, & Teasdale, 1978). In general,
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somatic attributions have been shown to be correlated with poor physical
functioning, increased number of chronic complaints, and increased health care use
Taillefer, Kirmayer, Robbins, and Lasry (2002). Additionally, the need for medical
assessments and corresponding treatments were more strongly correlated with
somatic attributions as compared to psychological attributions (Rief, et. al, 2004).
More recently, this concept provided some insight into the possible development and
maintenance of somatization as well as its effect on motivation for treatment. In fact,
attribution theory will be further discussed in the next section as one of three
dimensions of a cognitive model to explain motivation of patients to engage in
mental health therapy along with medical care.
An example of a positive attribution for bodily sensations is the
normalization of symptoms. Normalizing of symptoms was found to be one of the
main distinguishing factors in high and low utilization of health care in a study by
Sensky, Macleod & Rigby (1996). Patients with frequent visits (an average of 12
visits in a year) to their medical provider and a matched comparison group (on sex
and age) that hadn’t see their provider in a 2-year period were assessed. Those
patients with frequent visits were less able to generate normalizing attributions for
their physical symptoms and less likely to initiate a normalizing attribution as their
initial response, compared to the comparison group. Their health costs related to
visits were much higher than those of the comparison patients. An example of a
negative attribution can be observed in a study by Rief, Hiller, and Margraf (1998).
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Patients who had a restricted view of health and who believed they were weak also
had a lower threshold for stressful events and lower tolerance of body complaints
than a clinical comparison group which did not had not been diagnosed with
somatoform disorders. Those with somatization and hypocondriasis were found to
interpret somatic sensations in a catastrophizing way and construed even the slightest
discomfort or even fatigue as a disease. Additionally, those who had these negative
attributions were more likely to have poorer outcomes than those without these
diagnoses.
The relationship between other causal attributions and psychological
adjustment for patients with somatic complaints were examined in a meta-analysis
conducted by Roesch and Weiner, 2001. The results of the review found that those
patients with internal, unstable, and controllable attributions about their physical
symptoms were more positive about their ability to do something about their illness
(coping) and they used more emotion-focused and cognitive approach strategies that
those with external, unstable and controllable attributions. This latter group was also
shown to experience more negative beliefs and lower expectancy for coping with
their illness. They employed a more avoidance coping approach and had poorer
psychological adjustment.
In a review by Rief and Broadbent (2007), it was suggested that attributional
styles are perhaps multi-dimensional rather than one-dimensional. Patients who were
diagnosed with somatization may have two to three different illness attributions and
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these led to different problems. However, the extent to which individuals have fixed
and rigid attributions may contribute to the negative interactions during the
consultation between patient and medical provider. These negative interactions, in
turn, could lead to dissatisfaction as well as increased utilization of health care.
Expectations/Perceptions.
Studies have demonstrated that expectations can affect the perception of
suffering associated with illness. For example, in a study by Lorenz et al. (2005),
participants who anticipated lower intensity of pain, which was experimentally
induced, did in fact experience less intense pain compared to those who anticipated
higher intensity of pain. Lorenz et al. suggests that developing expectations of bodily
complaints can serve as a primer for scanning and interpreting future physical
sensations. Similarly, perceptions can influence somatic symptoms. Those with
medically unexplained symptoms appear to perceive themselves as having a strong
sense of bodily weakness (Reif, et al., 1998). A 2-year follow-up study by
Frostholm, et al., (2007) examined whether perception were associated with selfrated health. The factors were referred to as illness perceptions and included illness
identity label, control, consequences, emotional representations (helpless and
hopeless), and timeline. Approximately 1785 patients (ages 18-65) from 28 general
practice clinics completed the study. Patients were enrolled during a 3-week period
and diagnosed by their physician as having medically unexplained symptoms or a
specific presenting physical disease. Both groups were asked to complete an illness
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perception questionnaire at the beginning and at 3, 12 and 24 months. Linear
regression analyses revealed that negative illness perceptions were demonstrated to
be more evident in patients with somatization and predicted changes in their health
status over a two-year period. Studies of somatization have also used the expectancy
to measure motivation for therapy (Timmer, Bleichardt & Rief, 2006; and Schneider,
Klauer, Janssen & Tetzlaff, 1999). For example Timmer, et al., investigated the
relationship between patient’s initial motivation for cognitive therapy and 12-month
follow-up changes in their physical symptoms. Their study showed that improvement
in somatic symptoms occurred for those who took a more active role in, and
demonstrated more favorable attitudes towards psychotherapy. However, these
findings need to be understood in the context of correlational analyses that cannot
distinguish whether expectations affect somatization or the other way around.
Depression.
Depression and somatization seem to be risk factors for one another (Rief,
Schefer, Heiller, & Fichter, 1992), and both are correlated with reduced threshold for
pain. However, somatization can present with or without depression. Somatization
and depression seem to be associated with different measures of pain (Henningsen,
Zipfel,& Wolfgang, 2007). Sherman et al., (2004) examined the associations with the
perception of pain in women with somatization and depression. Although this study
examined these women’s responses that were diagnosed with a limited disorder
(temporomandibular disorder), findings revealed that attentional and perceptual (pain
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sensitivity) measures of pain were closely associated with somatization and
behavioral (pain tolerance or avoidance) measures of pain were strongly correlated
with depression.
Health Anxiety.
Health anxiety and illness worries appear to be positively correlated with the
onset and prediction of somatic complaints (VerKuil, Brosschot, & Thayer, 2007). It
has been suggested that illness anxiety is negatively associated with improvement or
diminution of symptoms. A cycle results in which rumination over symptoms leads
to increased attention to symptoms which leads to amplification of pain and illness
(Ursin, 2005). In a study by Hadjistavropoulos, Craig, and Hadjistavropoulos (1998),
782 undergraduate psychology students completed an illness questionnaire. A
random selection of those with health anxiety and those without health anxiety were
randomly assigned to receive different diagnostic information about their condition.
Participants with health anxiety (defined as negative interpretations and behavioral
responses that could lead to increased reassurance seeking) or non-health anxiety (as
measured by Illness attitude Scale) were given positive or negative feedback
regarding their symptoms. Those with health anxiety were less likely to draw on
optimistic health information, less likely to use flexible observation skills for
monitoring physical symptoms and less likely to engage in protective strategies,
compared to those with non-health anxiety. Health anxiety can also lead to excessive
scanning. For example, Barsky and Ahern (2004) demonstrated that there is a
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tendency for those with somatization to be hypervigilent towards stimuli and this
tendency is related to their health outcomes.
Sensitization.
Types of sensitization appear to contribute to somatization (Verkuil, et al.,
2007). Sensitization is considered to increase the possibility of medically
unexplained symptoms through amplified processing of physical problems.
Sensitization can be thought of as a multifaceted process involving the dynamic
interplay of cognitive, somatic, and neurobiological factors. This formulation of
sensitization can be used to help more concretely describe how somatization might
be developed or maintained.
Cognitive sensitization is biased for selective processing of information. A
study supporting this type of sensitization found that individuals had a tendency to
disproportionally remember information centered on health issues (Martin, Buech,
Schwenk, Rief, 2007). Another example of cognitive bias is found in a study with
individuals who were given information about a specific physical health condition.
Those individuals with health anxiety were biased towards a negative interpretation
of their condition compared to those individuals without health anxiety
(Hadjistavropoulos, Craig, & Hadjistthatavropoulos, 1998). Rygh et al. (2005)
suggest that not only anxiety, but depression, stress, and attention can alter the
processing pathways beginning with the sensation of a stimulus to the physiological
and psychological experience of pain, resulting in a lower threshold for discomfort.
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In other words, a benign sensation can be interpreted as a painful experience
depending on the level of anxiety, stress or attention associated with it.
Somatic sensitization is the awareness of bodily symptoms and sometimes
referred to as somato-sensory awareness (Burton, 2003). Those with somatization
seem to be not only more aware of physical symptoms, but intensify them as well.
An example of somatic sensitization can be appreciated in a study by Barsky, Ahern,
Bailey, & Delamater (1996) who showed that those with normal tests but who had
elevated levels of body awareness had increased sensitivity to the heart beating
faster. Heightened body (somato-sensory) awareness also seems to affect the number
of physical symptoms and corresponding pain tolerance. Those individuals with a
high awareness of somatic processes also have a higher number of physical
complaints and a lower pain threshold (Verkuil et al., 2007).
Neurobiological sensitization could be considered as another type of
sensitization that involves deregulations in the hypothalamus pituitary adrenal (HPA)
axis that is thought to be associated with medically unexplained symptoms (Roelofs
& Spinhoven, 2007). This complex communication system is comprised of the
hypothalamus, pituitary, and adrenal glands. It interfaces with the nervous and
immune systems and modulates stress by adjusting cortisol production,
neurotransmitter activity, and certain hormones. Any deregulation or abnormalities
in the HPA axis can cause a cascade of problems and symptoms. Among these are
anxiety, depression, and intolerance to stress and physical complaints. Chronic
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environmental stress such as adverse life events, worry, and rumination are thought
to contribute to protracted activation or “heightened neural or neuroendocrine
response” (Brosschot, Pieper, & Thayer (2005). This protracted response is referred
to as allostatic load, which has been linked to somatic complaints (Eriksen & Ursin,
2002).
Summary
Based on the aforementioned discussion, Figure 1 presents patient
characteristics thought to pose a risk for the development of somatization. It is
important to note, however, that these characteristics are derived from a viewpoint
that is partial to psychological sequelae and based on correlational findings.
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Bias towards Mental Health Explanations
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Figure 1. Diagram of characteristics associated with somatization.

The dualistic orientation (the dominant position being physical) through
which our society views certain problems like somatization tends to explain the
unexplainable by locating the mechanism of cause within the individual. If the cause
is not physical, it must be psychological. Since psychological symptoms, compared
to physical symptoms, continue to generate stigma, patients may unfairly internalize
blame and responsibility for their health problems. Stigma can further lead patients
to believe that their symptoms must be all in their heads and/ or they might be crazy.
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Although psychological characteristics have been shown to be associated with
medically unexplained symptoms, they are not yet fully understood and their effects
are difficult to isolate from each other. Regardless, these characteristics, along with
physical factors, merit concern and warrant consideration within the integrative
treatment plan approach. A fully comprehensive treatment paradigm must consider
physiology, personality, life experiences, cognitions and physician-patient
interactions.
The next section highlights both dualistic and integrative treatment
approaches that have been used to assist patients with somatization.

Treatment Models
Medically Oriented Approaches to Intervention
Findings from several studies quantifying discrete and helpful
communication for the medical provider and patient form the basis of medically
oriented approaches (Salmon, Ring, Dowrick, & Humphris, 2005). These approaches
have shown modest improvements in patient satisfaction; yet, only marginal and
inconsistent improvement in physical and psychological symptoms. These results
occur even with the newly minted versions integrating a mental health component
offered by physicians. Furthermore, none of these models seem ideal for those with
somatization (Ring, et al., 2005) because they are largely based on the reattribution
framework with extensions referred to as collaborative care.
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The reattribution model is a patient-centered, structured consultation
delivered by a physician and has three main components: helping patients feel
understood, broadening the agenda, and making a link between physical and
psychological mechanisms (Goldberg, Gask & O’Dowd, 1989). Only a few studies
have found this model to be helpful in attenuating somatic symptoms but not the
emotional symptoms that accompanied them (Dickinson, Dickinson, deGruy, et al.,
2003; Larish, Shweickhardt, Wirsching, & Fritsche, 2004; Morriss et al., 2007).
Morris et al. conducted a cluster randomized controlled trial of 16 practices for
which general practitioners received reattribution training. They compared those
patients who had medically unexplained symptoms and received the reattribution
model and those patients who received care as usual. The controlled trial failed to
show that the reattribution model led to improved outcomes for these patients. For
those studies (Morriss et al, 1999; Torgerson, 2001) that found positive findings for
patient health outcomes, there were serious methodological problems. Morris, et al.
describes some of these limitations as lack of randomization and contamination in
the treatment and control groups.
Emphasis on patient centered communication strategies can also be seen in
other versions of the medically-oriented model. Collaborative Care models have
adopted a biopsychosocial framework incorporating reattribution concepts with
medical providers delivering most if not all care. This model consists of a sequential
process (5-step patient centered communication to promote relationship) and a 3-step
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process to educate and promote treatment (Smith, et al., 2003, 2006). Physicians or
nurse practitioners are taught a protocol which includes a modified version of
cognitive-behavioral treatment. The Collaborative Care model is essentially the same
model but emphasizes integration of appropriate disciplines that may include
professionals such as physical therapists, pain therapists, social services, and
psychological services. Smith et al. (2006) showed that a multidimensional
intervention (patient-centered, CBT principles, antidepressants, exercise relaxation
train, physical therapy, and by primary care provider), delivered by primary care
personnel to 200 patients with medically unexplained physical symptoms, led to
overall mental health improvements in those with somatization (OR=1.92).
However, it remains unclear how much the improvements in mental health function
was accounted for by CBT over the other treatments. This study, however, is perhaps
the best prototype for integrated care for somatization as it incorporates both
physical and mental health care. It is worth mentioning that in this model, mental
health services are offered “only as needed on an individual basis” (Smith et al.,
2003, p. 479). Counseling is promoted when patients are diagnosed with severe
depression and after antidepressants fail. Mental health treatment is considered an
adjunct to care rather than a treatment that stands alone. It is not usually offered at
the beginning of care, but later when physicians observe that the emotional problems
are interfering with medical protocol. Similar models have been developed in other
countries such as China and Italy where the goals are improved integration of
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physical and psychological services, increased referrals to mental health by
physicians, and increased patient acceptance of mental health (Yeung et al., 2004;
Berardi et al., 2002). However, physical and psychological outcomes associated with
this medically-oriented consultation model continue to be under review.
There is some support for another type of medically-oriented model in which
the physician treating the patient receives a written consultation letter from a
psychiatrist who provides education and treatment management (Rost, Kashner, &
Smith, 1994; Smith, Monson, & Ray, 1986). Smith et al. (1986) randomized 41
patients with somatization disorder to a condition in which the physician received a
consultation letter or to a control condition (waitlist). At a 3-month interval, patients
were evaluated by research assistants who were blind to group assignment.
Compared to the control group, the group for which physicians were provided with a
consultation letter had a 53% decrease in health care expenses, which was largely a
result of decreased hospitalization costs. There were no changes in physical or
psychological status in either group. This study was replicated using a larger sample
by Rost, et al., 1994 with similar results.
One variation of this model was studied by van der Feltz-Cornelis, van
Oppen, Ader, & van Dyck (2006) in which a psychiatrist accompanied the physician
during the consultation process with the patient. General practice physicians were
given training in basic cognitive behavioral techniques (CBT). The findings revealed
a decrease in the severity of patients' chief unexplained somatic symptoms. It should
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be noted that these countries have institutionalized socialized medicine. The costs of
a simultaneous visit by both the psychiatrist and the physician, along with the time
that is required for the physician to provide even a diluted version of CBT, is often
prohibitive in the United States.
There are proponents from countries with socialized medicine, namely Spain
and the UK, that have found significant but modest effect sizes for general
practitioners (GP’s) providing mental health intervention. Aiarzaguena, et al., (2007)
showed that teaching GPs psychosocial and communication intervention skills can
help improve patient's overall quality of life, but with only modest effect sizes. The
argument for having the GP’s carry out an attenuated psychosocial intervention was
that patients would find it more acceptable. It would in essence be more in line with
the patient’s self-concept if psychological treatment were provided in a medical
setting. However, these authors concluded that interventions provided by specialists
in mental health produced larger effects and many of these patients would fair better
with therapy delivered by them.
While these medically-oriented models have demonstrated positive outcomes
with those who have medically unexplained physical symptoms, they pose inherent
problems that might be overcome with the more holistic approach offered in the
current study. Derived from the literature, the following list summarizes key
problems with medically-oriented treatment models.
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1.

Medically-oriented models typically do not provide comprehensive care from

the start of treatment. The attribution model has shown to be somewhat helpful, but
it may not be as effective if offered alone—without mental health therapy (Kirmayer
& Looper, 2006; Morris et al., 2007).
2.

Costs savings for these models has not yet been substantiated. The

collaborative care model has performed fairly well and has shown improvement in
mental function, depression, physical disability and depression. However, it was not
shown to have a cost advantage over care as usual (Luo et al., 2007).
3.

Many private practice clinics do not have sufficient resources to implement

these models. Many private practice clinics lack the funding, time, and staff required
by these models. Findings from studies conducted in HMO settings or in countries
with socialized medicine cannot necessarily be translated to private practice clinics.
4.

The onus for the entire range of care is on the physician. The common thread

across these models is reliance on physicians or other medical providers to learn how
to deliver and be responsible for the outcome of care. Research has demonstrated
that medical providers find it difficult to integrate the reattribution model in primary
care (Dowrick et al., 2008). Some of these barriers include patients’ deep rooted
beliefs about the causes of their symptoms, time limitations and complexity of
patients’ presentations. Salmon and others have examined physicians’ reluctance to
not only deal with these patients but also to obtain the training required (Morriss et
al., 2007; Salmon et al., 2007).
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5.

Medically-oriented models typically provide inadequate treatment of

concomitant psychological issues. Many patients present with comorbid
psychological issues which these models do not address and which could interfere
with or derail treatment for those with medically unexplained symptoms. In the
collaborative care model studied by van der Feltz et al., 2006), 70% of patients had
co-morbid psychiatric disorders. It has been demonstrated that a history of childhood
abuse and associated family dysfunction are more likely in patients with MUS than
in those with physically explained symptoms (Katon, Sullivan, & Walker, 2001;
Barsky, & Ahern, 1996). Even though medical providers routinely treat depression
and anxiety, psychological issues such as PTSD and abuse might not be easily
identified or appropriately treated. Primary care providers are not necessarily adept
at assisting patients with psychological challenges (Dowrick et al. 2008). CBT
application requires a fundamental knowledge of the therapeutic process as well as
specific training in, and practice with, the technique. In a study conducted by
Aiarzaguena, et al., (2006) in which patients were randomized to a collaborative care
model or a care as usual condition; the authors conceded that those patients with
complex psychological problems could have benefited from more mental health
treatment.
Summary
The provision of mental health therapy is more effective when delivered by
mental health specialists. While Smith, et al. (2006) demonstrated that physicians
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can treat patients with medically unexplained physical symptoms using the
collaborative care model, treatment was conducted within an HMO. This venue
offers advantages that many private practice clinics do not have. The current
reimbursement structure for medical providers in this country would likely be a
limitation for providing the quality psychosocial intervention that is available
through mental health specialists. Finally, research has shown that medical providers
are not willing to be trained in these models and do not necessarily want to address
psychosocial problems (Salmon et al., 2007).
Mental Health Oriented Approaches to Intervention
Part of the difficulty in assessing mental health treatment for somatization has
been synthesizing the amalgamation of studies which use different diagnostic criteria
such as single vs. multiple symptoms; overlapping psychosocial interventions (some
use cognitive treatment, others cognitive with behavioral treatment); individual and
group treatment; various types of professionals other than trained therapists; and take
place in different levels of care (primary vs. secondary). Additionally, the
interventions studied have addressed several different outcomes including physical
symptoms; reduced physician visits, intensity of symptoms, etc. There are several
systematic reviews and randomized controlled studies examining studies that focus
on somatic complaints and CBT, however, some of the conclusions are based on a
loose definition of CBT. For example, in some of the studies reviewed, CBT is
referred to as cognitive, behavioral, or relaxation therapy or a combination.
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In spite of some of the methodological challenges, there is consensus that
psychological therapy and CBT in particular can be effective (Brown, 2007; Deary,
et al., 2007; Roelofs & Spinhoven, 2007). CBT is thought to help the individual
address maladaptive beliefs about and coping with symptoms.
Cognitive Behavioral Treatment: Systematic Reviews and RCTs.
The effectiveness of CBT for somatization has been examined by a number
of investigators (e.g., Kroenke & Swindle, 2000; Looper & Kirmayer, 2002; Raine et
al., 2002; Sumathipala, 2007). Their studies have consistently demonstrated positive
results for this particular type of mental health therapy.
A critical review offered by Kroenke and Swindle, (2000) found that
cognitive-behavioral therapy (CBT) was promising for those with somatization.
They identified 29 randomly controlled trials in which 71% of the patients with CBT
demonstrated more improvement in their physical functioning as compared to those
in the control conditions. They recommended that CBT could be used as first line
response or as an adjunct to the stepped care model used by physicians for treating
these patients. That physical symptoms were improved independent of psychological
distress suggests that reduction in physical symptoms may be mediated through
distressing cognitions rather than through depressive or anxiety symptoms. Thus,
targeting coping, illness worry and catastrophizing may attenuate physical problems.
It was recommended that since many studies find patients are unwilling to engage in
mental health therapy, future studies should examine those with somatization who
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are offered CBT and actually accept. It also seems reasonable to investigate how and
who offered them, and what barriers were encountered.
In another systematic review by Raine et al. (2002) of 61 studies, it was
concluded that cognitive behavioral therapy (which also included graded exercise),
had a substantial effect on somatic symptoms of those with back pain and chronic
fatigue. However, both graded exercise and cognitive therapy demonstrated a large
effect size in secondary care (mental health specialist) only and not primary care
(individual who were recruited from the community or by their primary care
physician). A review (aggregating studies of IBS, CFS, fibromyalgia, and
somatization) by Allen et al. (2002) of 34 randomized, controlled studies, using
many of the same studies as Raine, concluded that only a modest effect size was
found for psychotherapy interventions and that the studies were of short-term
duration.
Looper and Kirmayer (2002) provides a descriptive review of approximately
30 randomized controlled studies that found support for the effect of cognitive
behavioral therapy in primary care for several types of somatoform disorders
(hypochondriasis, undifferentiated somatoform, chronic fatigue syndrome and
noncardiac chest pain). The largest effect was found for a reduction in somatic
symptoms. For example, in Speckens, et al., (1995) study of medically unexplained
symptoms, effect size for patients with CBT at 6 months was .54 while in McCleod,
Budd, and McClelland (1997), at 6 months was .43.
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In addition to these reviews, there have been several other studies
investigating the effects of CBT on individuals with somatization. Bleichardt,
Timmer, and Rief (2004) conducted a randomized controlled trial of CBT in tertiary
care (psychiatric hospital) and, after a one-year follow-up; they found a large effect
size (Cohen’s d= 1.22) for reduction in number of symptoms. Hiller, Fichter, and
Rief (2003) also found modest effects for CBT on somatic symptoms in tertiary care
(Cohen’s d=. 58).
In a randomized clinical trial study of cognitive-behavioral therapy with
somatization patients, Allen et al., (2006) found that the intervention group,
consisting of CBT and psychiatric letter with recommendations to the physician,
showed greater improvement over the control group (psychiatric letter only). Those
in the intervention group were 8.3 times more likely to be rated as improved at 3
months; 11.6 more likely at 9 months and 12.7 at 12 months. There was a reduction
in physical complaints as well as decrease in health care costs.
A study conducted by Escobar et al., (2007) demonstrated the potency of
time limited CBT for patients with somatization. Among 172 individuals with
medically unexplained symptoms receiving CBT, were 4.1 times more likely to be
rated as improved in physical symptoms by the clinician. Similarly, in another
randomized controlled trial, Martin and colleagues (2007) found that one-session
CBT compared to care as usual, made a significant difference in both number of
doctor visits and severity of symptoms for those with somatization.
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In a more recent investigation, Sumathipala (2007) examined five systematic
reviews and 29 randomized controlled trials on treatment of somatization in the US,
UK, Netherlands, Australia, Sweden and Germany in primary, secondary and tertiary
care. The strength of evidence for the effectiveness of interventions was based on
type of study design and the assigned score using a hierarchy (e.g., Level I or Level
II). Level I evidence was based on systematic reviews and level II evidence was
based on randomized controlled trials (RCTs). The only level-1 evidenced-based
treatment for medically unexplained physical symptoms appears to be CBT delivered
by mental health professionals. In this review, those receiving CBT improved in
physical symptoms more than control subjects did in 71% of the studies.
In sum, neither medical nor psychological models can singularly address
somatization effectively. It is noteworthy that some of the studies assessing the
effectiveness of medically oriented models for treatment of somatization consider
both medical and psychological care. Yet, in studies examining the impact of
psychological care for somatization, a discussion of medical care is essentially
absent in the treatment protocol. Still, medically oriented models that offer a
combined physical and psychological treatment plan fail to demonstrate the
effectiveness of the mental health component. When mental health therapy is
delivered by physicians and medical practitioners rather than trained mental health
professionals, the effect is not as strong or absent (Luo, Goddeeris, Gardiner, Smith,
2007). This may be due to the different interpretation and delivery of CBT. For
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example, CBT was defined as cognitive restructuring using diaries, scheduled visits
and medications.
However, the role of the medical provider during the medical consultation is
central for encouraging patients to seek mental health treatment. The next section
will discuss a promising approach to facilitate a combined treatment plan for patients
with somatization.
The Medical Consultation Process
Given that patients will likely initiate visits from the primary care provider,
the patient-physician consultation becomes the focal point for a successful referral to
mental health therapy. The consultation process is the juncture at which medical
professionals interact with patients to help address these issues, assuage fears,
influence views about symptoms, and propose what treatment might work best (Di
Blasi, et al., 2001). But the consultation process is also fertile ground for potential
alienation of the patient. Both provider and patient factors can affect the quality of
the consultation process and can have important consequences for the treatment
trajectory. A discussion of provider and patient factors that intersect and often collide
during consultation helps to identify and inform strategies that could foster the
coordinated delivery of mental health therapy with physical treatment.
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Provider Factors
Medical providers affect how patients perceive their symptoms, patient's
expectations for the direction and type of treatment, as well as patient's responses
during the consultation process (between medical provider and patient). A systematic
review by Di Blasi, et al., (2001) examined 19 randomized controlled trials in which
the physician’s responses affected patient’s expectations about treatment. Ten of
these trials found significant effects for practitioners who influenced patient’s views
about the effect of a therapy and who had strong impact on patient’s health
outcomes. Many of these responses can be categorized as rejection, collusion,
confrontation and empowerment (Salmon, Peters & Stanley, 1999; Salmon, 2007).
Rejection.
Medical providers have been shown to marginalize patients with somatization
by stereotyping them as “frequent attenders” “difficult” or “heartsink”(Bensing &
Verhaak, 2006; Bergh, Baigi, Fridlund & Markland, 2006; Butler & Evans, 1999).
The term “heartsink” speaks to the frustration and sometimes exasperation that
physicians feel towards patients with unexplained medical symptoms. This
frustration often leads to disregard for patient’s complaints and the assumption that
symptoms are invalid (Wileman, May, Chew- Graham, 2002). When providers deny
a patients’ reality, they may tacitly suggest that patients are imagining their
symptoms and are therefore culpable. (Salmon, Peters, & Stanley, 1999). Providers
can even feel hostile towards these patients. Many providers are left confused about
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the uncertainty of motives for presentation and legitimacy of patients with
somatization, this can lead to premature “disposal” of the patient (Chew-Graham,
2005).
Collusion.
Collusion is described as “sanctioning the patient’s beliefs by acquiescence”
(Salmon, Peters, & Stanley, 1999, p. 373). Medical providers often do not feel
equipped to deal effectively with somatization and may instead yield to the patient’s
suggestions (Hartz, et al., 2000). Medical provider’s treatment decisions, however,
may be based more on their perception of patient’s wishes than the patient’s true
preferences (Salmon, et al. 2005). It also has been demonstrated that some medical
providers adapt their biomedical interventions at least in part to presumed patient
preferences (Cockburn & Pit, 1997). They overestimate patients’ wish for
biomedical interventions. These interventions include prescriptions and referrals, and
are thought to contribute to and perpetuate somatization (Little, Dorward, Warner, &
Stephens, Moore, 2004). Collusion can backfire; especially when a physician too
readily accepts the patient’s explanation. This response ironically leads to the
patient’s lowered confidence in the provider’s expertise (Salmon, Peters & Stanley,
1998).
Confrontation or Criticism.
Medical providers typically do not value or want to provide psychological
support to patients (Salmon, et al. (2007). Even with overt cues from patients for
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emotional reassurance, physicians are reluctant to respond to this request, especially
for those with somatization. Yet, many providers believe and suggest that patient’s
physical symptoms stem from psychological issues. These psychological
explanations for patient’s symptoms are often interpreted by patients as
confrontation or criticism. Using a qualitative design, Salmon recorded and coded
medical consultations between patient and their physicians to examine physician’s
motivation for communication with the patient that was labeled criticism or
confrontation by the patient. It had previously been suggested that this style of
communication was a way for the physician to avoid emotional engagement.
However, Salmon found that a rationale underlying physicians withholding of
emotional support was the belief that it is better for the patient since it would reduce
dependency and facilitate patient responsibility. Thus, while engaging in a
confrontation style is done with the patient’s best interest in mind, unfortunately it
seems to have a deleterious impact on the consultation.
Empowerment.
Empowerment is a particular feature of consultation that cultivates
collaboration. It promotes patient’s skills and strengths that are needed to manage
their symptoms. The underlying message conveyed is one that removes blame and
stigma (Salmon, et al., 1999). Salmon (2005) recommends that providers include
tangible, exculpatory explanations grounded in patient’s concerns and views as a
more effective in the communication process between medical provider and patient.
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While this patient-centered focus appears to promote the most favorable response by
the patient, it is infrequently communicated.
Patient Factors
Those with somatization have been shown to have unrealistic expectations,
to exhibit non-compliance with treatment, and to have unsuccessful treatment
outcomes (Oyama, Paltoo, & Greengold, 2007). Additionally, these patients
have frequent interpersonal conflict with medical staff attempting to help them.
These behaviors and associated difficulties appear to arise from, and are influenced
by, the patient’s self-concept.
Self-concept
The self-concept or self-identity can be understood as an organized mental
structure or representation of how we see, view, think, perceive, and understand
ourselves (Kilhlstrom & Kilhlstrom, 1999). It is composed of more permanent
characteristics such as attitudes, beliefs, skills, abilities and personal attributes that
make up the real self, the perceived and the ideal self. Incongruence is a lack of fit
between these components and becomes a threat (Farber, Brink, & Raskin, 1998).
The individual defends against this threat through denial and distortion in order to
cope with the ensuing anxiety. These defenses thus serve as protection when the selfconcept is incongruent or does not match behavior. Physical symptoms promote
cognitive and emotional reactions that, in turn, create a need to make sense of what is
happening (Leventhal & Cameron, 1987). In keeping with their self-concept,
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individuals attempt to understand what might cause their symptoms, how long they
will last, and ideas about what might help them get better. The very notion that
medically unexplained symptoms are thought to impersonate psychological distress
can indirectly challenge the patient’s self-concept through questioning their
legitimacy (Werner, Isaksen, & Malterud, 2004; Peters, Stanley, Rose, & Salmon,
1998). This is often what happens during a medical consultation. The patient’s self
concept embodies an illness representation that is organized around the belief that
symptoms are physical and the medical provider, having ruled out medical etiology
believes the symptoms are psychological. This conflict increases the risk of patients
feeling humiliated and a negative outcome of consultation.
Several qualitative studies have shown that patients with somatization tend to
be reluctant to consider psychological explanations because doing so directly
challenges their self concept (Werner, Iisaksen, & Malterud, 2004; Nettleton, 2006,
May et al., 2000; Rhodes et al., 1999). Mays et al. (2000) examined patients with
chronic pain and demonstrated how patients engaged in strong efforts to avoid the
possibility of being labeled as having a psychological problem, especially since it
was incompatible with their beliefs about themselves. Nettleton (2006) found that
patients with medically unexplained symptoms had a high need for legitimacy,
which was difficult to maintain when providers begin to discuss possible
psychological explanations. Rhodes et al. (1999) conducted a study of patients with
back pain and found that those patients whose medical tests substantiated their
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somatic condition felt vindicated and legitimate. Conversely, those patients who
were unable to secure evidence for their pain felt “de-legitmated” (p.1201). When
medical providers in the consultation process attribute an emotional cause to physical
symptoms, many patients feel inadequately cared for, offended, and that their
suffering has been “psychologized” (Bensing & Verhaak, 2006). Additionally,
patients will likely maintain their position that their problem is physical and they will
be reluctant to consider mental health treatment. That patients are reticent to
entertain the notion of psychological treatment might be related to stigma, which can
accompany any discussion of mental health care. These studies underscore how
important it is for the provider to suggest a treatment plan that neither labels the
problem within one or the other category of etiology nor prescribes to one type of
treatment over the over. Instead, the central message that needs to be communicated
to the patient is that etiology may be unknown, but that integrative care can be most
effective in easing the physical symptoms and stressful issues that arise from
somatization.
A cognitive process affecting the self-concept is cognitive dissonance.
Specifically dissonance is stress caused by attempting to manage two opposing
thoughts or ideas simultaneously (Leary, MacDonald, & Price Tangney, 2005). This
process may help to explain why patients are so adamant about seeking care through
medical avenues and eschewing mental health treatment (Kihlstrom, & Kihlstrom,
1999). If they believe their symptoms to be somatic, then pursuing treatment by a
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medical provider is consistent with their self-concept. The act of going to a medical
provider rather than a mental health provider further justifies and corroborates what
patients might believe—that their symptoms are physical and should be treated using
physical intervention. And this response might work as long as the provider
substantiates the patient’s beliefs by agreeing to physical treatment.
Difficulties with Referring Patients to Mental Health Therapy
There has been much speculation but little known about how medical
providers can facilitate the discussion of mental health therapy with patients and
which approach can result in a successful referral. Studies have shown that while
psychological intervention is effective for somatization, it is typically not acceptable
to majority of patients (Barsky & Ahern, 2004; Kashner, et al., 1995; Kroenke, 2007;
Shaw & Creed, 1991; Schneider, Beisenherz & Freyberger, 1990; Sumathipala, et
al., 2000; Woolfolk & Allen, 2007). For example, Schneider and his colleagues used
a number of scales to examine therapy expectations for 865 patients suffering from
different levels of somatopsychic disorders. These scales consist of statements that
reflect the subjective experience of the disease, lay concept, general attitudes and the
expectations concerning treatment, along with previous experiences with
psychotherapeutic concepts of treatment. The results of the study showed that
neurotic patients with primarily psychic symptoms demonstrate the highest
motivation for psychotherapy and patients with somatopsychic disorder had a
significantly lower motivation for psychotherapy than typical psychiatric patients.
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There also has been some speculation regarding how patients with
somatization may be inherently different in ways that set them apart from patients
with other medical or psychological issues. These differences may pose unique
barriers to mental health intervention (Dowrick, et al., 2008). Yet, only a handful of
studies have examined this issue. For example, Schneider & Klauer (2001) found
those who made psychosocial attributions for somatic symptoms were more
receptive to mental health treatment and also predicted better outcomes than those
with somatization who where characterized by lower openness. In other words,
patients who believed that their physical symptoms might be associated with
psychological problems (depression, anxiety, etc.,) were more amenable to engaging
in mental health treatment. Furthermore, these patients experienced better health
outcomes such as reduced fatigue and pain. Studies by Speckens, van Hemert, Bolk,
Hawton, and Rooijmans, 1995; Schneider, et al., 1990; and, Timmer, Bleichhardt
and Rief (2006) demonstrated that patients suffering from somatization would be
more likely to accept psychological treatment if they were younger and more
educated. These patients were also more likely to have higher levels of physical
complaints and distress, compared to older and less educated patients. Speckens et
al., specifically investigated whether patients with somatization were willing to
accept mental health therapy and how they might differ from those who find therapy
less acceptable. Findings from this study revealed that those with somatization
generally accepted referral for mental health therapy. Those that refused therapy had
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less severe physical symptoms. Possible explanations for these results were
considered. 1) The physician asked patients to participate, 2) acknowledgement that
psychological symptoms were equally likely a result of physical symptoms as the
cause of them, and 3) therapy would take place on the premise. These explanations
have some support in the literature. For example, when physicians endorse a
particular treatment modality, it seems to have a stronger impact than neutral a
neutral position (De Blasi, et al., 2001). Consequently, some believe that referrals for
psychological therapy are thwarted because medical providers fail to have
confidence in psychological treatment and are reluctant to suggest it (Brown, 2007).
Their reluctance stems from uncertainty about the preparation and qualifications of
therapists to manage the needs of those with medically unexplained symptoms.
Moreover, some medical providers may believe that psychotherapy is not as
important or essential to care and have conveyed this view when discussing why they
themselves are reticent to offer emotional support. A qualitative study by Salmon et
al. (2006) investigated why physicians were reluctant to be trained to improve
management of patients without medically explained etiology. Their statements
reflected a minimization and even a discounting view of psychosocial support to
patients by using the word “just”. For example, “it’s just supporting the patient”, p.
567. It seems that physicians are ambivalent, reluctant or do not value this particular
aspect of their role (Salmon, 2007).
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Patient centered models support and encourage providers to emphasize the
link between physical and mental symptoms but this can backfire. The suggestion of
psychological underpinnings can easily alienate the patient (Bensing & Verhaak,
2006). Timing is often critical. It has been recommended that referring a patient to
mental health therapy after exclusion of medical tests result in negative effects.
Additionally, Looper and Kirmayer (2002) advocate that treatment provided
in the context of medical setting “shared care” is more consistent with patient’s view
of care and therefore an acceptable option. This type of care implies that both
medical and emotional services are provided under one roof. Findings from a survey
showed that 50% of patients who were referred to social workers would have refused
to follow-up if it meant going outside the medical practice (Huntington, 1981).
Examining other populations that have identified barriers to mental health
treatment also may expand our understanding of treatment for somatization. Findings
from a study by Craske et al. (2005) showed that one of the greatest barriers to
mental health treatment among those with panic disorder in primary care was finding
out where to go for help. Other barriers included costs, timely appointments
scheduled by mental health provider, stigma, and embarrassment in discussing a
problem. It is possible that these barriers may also be present in those with
somatization.
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Summary
Extensive research has been aimed at identifying characteristics thought to be
associated with increased risk for somatization. However, these relationships are
based on correlational studies for the most part, which cannot distinguish the bidirectional possibilities or potential roles of intervening factors. Many of these
findings have informed medical and psychological models of treatment. However,
the resulting models fall short of truly integrating both components into a cohesive
approach to care for patients with somatization. For example, the patient-centered
care model has been established as the basic prototype of medical treatment for
individuals with somatization. This model’s contribution has been largely effective
in increasing patient satisfaction rather than in ameliorating patient symptoms
(Sumathipala, 2007). Additionally, there are expectations of the medical care
providers to be both medical and mental health practitioner, which doesn’t
necessarily translate to quality psychological care. To date, a model in which
physicians deliver the cognitive therapy component has shown to be ineffective
(Morriss, et al., 2007). On the other hand, the psychotherapy model has been
established as beneficial to both process and outcome, and it addresses both physical
and emotional symptoms. Yet, without the integration of a medical component,
patients are reluctant to take part in treatment. Along with mental health care,
medical care helps establish authenticity for patient’s symptoms eliminates blame
and provides ongoing observation and support for physiological concerns. Unifying
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medical and psychotherapeutic components of care can contribute to a more
balanced assessment and treatment plan that works towards amelioration of
symptoms and prevents the stigma that is inherent in the dualistic approach to
treatment.
The consensus in the literature favors a “balanced approach” such that
treatment focuses on both biomedical and emotional aspects (Henningensen, Zipfel,
& Herzog, 2007). This heuristic strategy provides the optimal arrangement for
addressing the fluid mind/body continuum of which somatization is firmly
embedded. The medical provider needs to stay on board to monitor and review the
physical complaints and determine if further investigation is required – all of which
promotes legitimacy and support for the patient. The focus and role of mental health
treatment are to help the patient manage physical symptoms, and to uncover, address
and cope with other stressors or issues that may be unknowingly linked to the
physical symptoms. The overarching message is that therapy can help with the stress
of symptoms rather than undercover latent psychological reasons why one has
symptoms. In this way, the combination of physical and mental support provides a
holistic way to address concerns of patients with medically unexplained symptoms.
Moreover, mental health treatment can help patients reconcile concerns about their
self-concept that might have been unleashed by the lack of objective tests to discover
and validate their physical symptoms.
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The consultation process between medical provider and patient creates an
ideal situation with which to formulate an integrative treatment plan in such as way
that values the fluid nature of symptoms while promoting the benefits of both
physical and mental health care. However, there is little known about how to
transcend conditions and barriers for patients who can benefit from psychotherapy.
This gap in the literature marks the need for the development of practical methods
for the medical practitioner to successfully enhance patient’s motivation for
psychotherapy during the medical consultation process.
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CHAPTER 3: THEORETICAL MODELS
Although there is strong support for a combination of physical and
psychological treatment approach to somatization, the dilemma of how to motivate
patients to engage in therapy remains. Motivation has been shown to influence
engagement, process and outcome of therapy (Bleyen, Vertommen, Steene, &
Audenhove, 2001; Deci & Ryan, 1985; Joyce, Ogrodniczuk, Piper, & McCallum,
2003. In particular, motivation plays a central role in the successful referral to mental
health therapy for individuals with medically unexplained symptoms (Looper &
Kirmayer, 2002; Rumpold et al., 2005; Schneider & Klauer, 2001; Timmer, et al.,
2006).
Motivation has been studied from a variety of different perspectives and it is
considered to be a continuous multidimensional construct for which there are several
micro and macro theories (e.g., Deci & Ryan, 1985; Freud, 1990; Maslow, 1943).
Out of the several theories that have been used to explain motivation, there are three
that appear to have the greatest explanatory value in describing a patient’s
motivation for mental health treatment: cognitive dissonance, attribution, and
expectancy theories. These interrelated theories share an overarching cognitive
framework which implies that information processing (which guides thoughts,
emotions, and behaviors) is a primary factor in motivation (Huitt, 2006).
Furthermore, patient factors associated with somatization, as already discussed in the
literature review, can additionally be informed by these theories. Figure 2 presents a
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diagram depicting the elements of each theory, and the following discussion
describes the application of each theory to understanding patient motivation for
therapy.
Cognitive Dissonance Theory
Cognitive dissonance is a theory that relates to an action taken in order to
mitigate internal conflict or discrepancy with regard to one’s beliefs and behaviors
(Festinger, & Carlsmith, (1959). The main tenet of this perspective (previously
discussed on page 39 under self-concept) is that being presented with information or
decisions which share two opposing views creates discomfort. Individuals will want
to eliminate the distress and further avoid situations that will continue or intensify
the imbalance. For example, some patients with somatization might lack motivation
to engage in mental health therapy because they believe that the act of participation
in mental health treatment validates that they are crazy or that they are imagining
their physical symptoms. These beliefs are incompatible with their views about their
mental health. In an effort to avoid this internal conflict, patients may simply avoid
or refuse this type of treatment and continue their pursuit of medical treatment.
Reconciling this discomfort will have a strong impact on patient motivation to
participate in therapy and dissonance can be addressed during the consultation
process between patient and provider.
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Attribution Theory
The main premise of attribution theory is that people think and behave
depending on how they experience, interpret and assign causes for events (Weiner,
1986). Attributions provide a framework with which an individual makes
assumptions and understands the world, and from which his or her future cognitions
and actions will be made. Extending this framework to health, attributions are made
about diagnosis of a health problem and treatment. Patient's attributions about their
illness will guide their decisions about coping and motivation behaviors (Michela &
Wood, 1986). Heider (in Weiner, 1974) examined the polarity of internal versus
external attributions as the primary type of attribution underlying and explaining
motivation for behaviors. However, others have expanded this dimension to include
the polarities of positive vs. negative, controllable vs. uncontrollable, stable vs.
unstable, physical vs. psychological (Weiner, 1974; 1986; Roesch & Weiner, 2001;
Sensky, 1996). According to Weiner’s theory, those individuals with stable, external
and uncontrollable attributions have lower expectancies for future improvement and
they can be resigned to believe that nothing can be done. In contrast, those with
unstable, internal, and controllable attributions tend to expect that circumstances can
be changed, controlled and lie within the individual to execute.
The type of attributions patients with somatization have about their
symptoms have been shown to predict their behaviors directed toward engaging or
avoiding treatment (Michela & Wood, 1986). For example, if patients attribute a
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physical cause for their symptoms, they may not be able to appreciate how
addressing psychological processes in conjunction with physical care might be
helpful. Deale, Chalder and Wessely (1998) examined the differential effects of
attributing physical versus psychological attributions to symptoms of chronic fatigue
syndrome and health outcomes. Sixty-five patients who attended a clinic for
treatment of fatigue were randomized into cognitive behavioral treatment or a control
condition. Measures of casual attributions about fatigue and activity were taken
before and after treatment. Those in the treatment group having physical attributions
did not change: they found no association between attribution for fatigue and poor
outcomes. However, at post treatment, fewer patients in the treatment group believed
that avoidance of exercise and activity helped their fatigue levels. Their changes in
beliefs about exercise and activity were associated with improved outcome for
fatigue and disability. Along with the change in outcomes came a change in their
causal attributions. Each of the different polarities mentioned above has different
implications for individuals with somatization (see page 21-22 for additional studies
that demonstrate how variable attributions are associated assessment and treatment
of somatization).
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Cognitive Dissonance
Attributions
Incompatible beliefs Equilibrium

control/uncontrolled positive/negative internal/external physical/psycho stable /unstable

MOTIVATION FOR THERAPY

Role, Control, Outcome

Expectancy

Valence

Instrumentality

Expectancy
__________________________________________________________________
Figure 2. Theories underlying motivation to engage in therapy.

Expectancy Theory
Expectancy is another theory in the cognitive framework which also helps to
explain motivation (Vroom, 1964). Although its formulation was first appreciated in
the work place, the role of expectancy theory for explaining motivation has been
subjected to wider application (Muchinsky, 2008). This theory has three central
propositions: Expectancy is described as the association between effort and
performance. In other words, how much you try and the result of your effort - the
harder you try - the higher the probability of how much better you will do. Valence is
the element which describes the individual’s perception of how satisfying or
attractive an outcome will be. Instrumentality is described as the individual’s
perception of the degree of association between performance and realization of the
outcome. Delsignore and Schnyder (2007) elaborate on the three types of
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expectancies that influence whether an individual will be likely to participate in
psychotherapy. Role expectancy is described as behavior congruent and expected of
individuals who inhabit a certain position (e.g., clients have expectations about the
appropriateness of themselves and therapist). Expecting to take an active and passive
role has been shown to affect the extent to which therapy is beneficial. Control
expectancy refers to the assigned effort attributed to the improvement: the client's
efforts (similar to internal or control) or the therapist’s efforts (external locus of
control). Outcome expectancy refers to how useful or helpful clients believe the
therapy will be to them.
Devilly and Borkovec (2000) define expectancy as a belief that
improvements can be obtained. Additionally, these researchers include credibility as
another dimension of the cognitive model of motivation to explain the variation in
levels of motivation to engage in mental health therapy. Credibility is defined as
“how believable, convincing, and logical the treatment is.” (Kazdin, 1979, p. 82).
This concept attempts to capture those clients that may believe the therapy is helpful
but not quite convinced it will work for them. Cognitive and affective elements
underlie both expectancy and credibility dimensions.

Application of Theories to Assessment of Motivation for Therapy
Having demonstrated their application to therapeutic motivation, these
theories can further be shown to form the basis of many instruments designed to
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measure motivation for therapy for those with somzatization. Cognitive dissonance
and attribution are among the dimensions measured to assess motivation for therapy
in the FMP by Schneider and Klauer, 2001. The cognitive dimension of expectancy
underlies the Credibility / Expectancy tool designed by Devilly and Borkovec
(2000). More specifically, Schneider, Klauer, Janssen, and Tetzlaff (1999) posited
that psychotherapy motivation is predicated on cognitive and general attitudes as
well as influenced by socio-demographic variables. They pulled together several
dimensions of cognitive theory and some of the tenets of psychodynamic theory to
develop the construct of motivation for psychotherapy. A conceptual model,
developed by Schneider, Basler and Beisenherz (as cited in Schneider & Klauer,
2001) was tested by Schneider and Klauer (2001) with the formulation of an
instrument called the FMP. This measurement included expectations of treatment
and likelihood of success, degree of distress (suffering), and causal attribution for
symptoms. Schneider and Klauer demonstrated that motivation for therapy among
those with somatization was related to openness to psychotherapy and psychological
attribution of the symptoms. Rompold et al. (2005) obtained similar findings for a
motivation-enhancing study using the FMP and the therapeutic alliance scale (TA).
A motivation-enhancing phase consisted of pretreatment up to 6 hours (3.9 sessions).
Measurements on the FMP and TA were taken and compared at Time 1 and Time 2.
Results from this study demonstrated that pre-therapy phased helped to increase
openness to psychotherapy and enhanced treatment expectations.
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Application of Theoretical Models to the Dissertation Study
The dissertation study integrates these cognitive-based theories of motivation
in an analogue intervention (enhanced consultation interview), and investigates
whether they significantly impact the provider’s ability to motivate patients to
engage in mental health therapy during the consultation process. The enhanced
consultation interview tested in the study incorporates these theories to address the
following five issues that are thought to be salient for patients and amenable to
facilitation of motivation.
1.

Patients are biased towards the treatment strategy that assumes the dualistic

nature of health care (McFarlane, et al., 2008). They anticipate labeling the symptom
etiology in one or the other category (somatic or psychological). This can become
especially pernicious when a medical explanation can’t be found for their symptoms.
These patients are left with a psychological one which causes internal conflict over
two opposing beliefs (cognitive dissonance). Patients may feel misbelieved and
begin to question their self-esteem (Nettleton, 2006). This challenge could lead to
blame and responsibility (Salmon, 2007). To avert this predicament, the provider
can, explain how physical and psychological causes are fluid with one or the other
being more prominent at any given time. Additionally, it can be communicated that
either physical or psychological factors or both may be influencing the presenting
symptoms. Moreover, it can be helpful to mention that emotional stress is
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inextricably related to physical symptoms; it may be difficult to separate physical
from emotional causes (attribution). These acknowledgements serve to deemphasize
the importance of etiology, obviate blame and further reduce need for patients to
defend the veracity of their beliefs (Speckens, et al., 1995). Finally, they can prevent
escalation of symptoms or the persistent requests for additional tests.
2.

Patients may assume that engagement in therapy will be conceding that the

symptoms are all in their head or that they must be crazy (Bakal, Steirert, Coll, &
Schafer, 2006). Patients may not appreciate the purpose of therapy - how it can help
manage or even attenuate some of the physical symptoms. This understanding can
help make therapy a more logical and attractive option (Valence). The idea that
thoughts, emotions, and behavior can contribute to symptoms as well as mitigate
them might have not been understood (Schneider, et al., 1990). Consultation can
further target apathetic, adverse and erroneous treatment expectations for mental
health therapy in order to dispel myths about mental health therapy. Specifically the
provider can discuss how therapy is a medium through which patients can develop
essential tools to combat the stress associated with physical symptoms. Patients can
then appreciate that their performance in therapy will lead to the improvement of
their symptoms (Instrumentality).
3.

Patients often fear losing the medical provider (Bakal, et al., 2006).

Consultation can address concerns about the dichotomization of care and reassure the
patient that mental health therapy does not come at the exclusion of ongoing medical
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care from the provider. Rather patients get a holistic approach in which both medical
and emotional support are provided. The amelioration of fear over losing their
medical provider reduces cognitive dissonance by eliminating the stress of sorting
out whether their problem is physical or psychological. Providing reassurance to
patients that they will continue their relationship with the medical provider also
addresses causal attributions. It sends the message to patients that their symptoms
are not their fault and warrant the type of support (external vs. internal) that medical
care can offer. The medical provider’s continued involvement also can serve as
evidence that the physical aspect of the patient’s condition is manageable
(controllable vs. uncontrollable).
4.

Patients can feel discarded or dismissed when mental health treatment is

introduced after all other investigations have been exhausted (Peters, Stanley, Rose
& Salmon, 1998). The provider must “time” the introduction of mental health
treatment so that it comes at the beginning of the consultation process rather than
when there are no further medical tests to do. Early introduction of counseling can
help normalize the integrative treatment plan, rather than giving the impression that
psychological treatment is offered as a last resort or in an effort to appease the
patient. This step can help prevent the patient from experiencing cognitive
dissonance. Patients don’t have to juggle two opposing beliefs. Treatment
presupposes that both physical and psychological symptoms are an inextricable
problem and at the very minimum require expertise of both disciplines.
72

5.

Patients may lose momentum for interest in mental health therapy due to

difficulty in navigating the referral process (Craske, et al., 2005). Having both
mental health and medical care sharing the same facility (proximity) can eliminate
obstacles often present in locating, contacting and requesting a mental health
therapist. (Looper & Kirmayer, 2002). Accessibility of the mental health worker in a
medical clinic is symbolic of integrative care and may help the patients loosen their
foothold on physical vs. psychological casual attribution. Patients can begin to
appreciate that the medical provider’s suggestion of obtaining psychological care is
comparable to the suggestion of seeking a medical specialist for further evaluation
and treatment. The physical vs. psychological dichotomy becomes blurred with both
types of treatment understood as the norm and expected from a thorough health
provider.

Summary
Cognitive dissonance, attribution and expectancies theories of motivation
provide a framework with which to begin to understand and evaluate how
information is processed and the degree to which it can exert influence on patients’
resistance or engagement in psychotherapy. In particular, these theories can inform
and guide an effective dialogue during the medical consultation, targeting the most
critical issues thought to influence patient motivation to engage in mental health
therapy. These issues include linking psychological and physical attribution of
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symptoms; dispelling myths about and explicating the purpose of psychotherapy;
reassuring the patient of the medical provider’s ongoing involvement and support;
and attenuating difficulties emanating from the referral procedures for mental health
(Looper & Kirmayer, 2002; Martin, et al., 2007; Salmon, 2007: Schweickhardt, et
al., 2007; Timmer, et al., 2006). The impact of these issues on patient’s willingness
to participate in therapy was systematically evaluated by examining patient response
to medical consultation. The following research questions were examined.
Research Questions:
1. To what extent will patients be motivated to participate in mental health therapy?
Hypothesis:
HO: Patients receiving the enhanced consultation interview will not show a
significant increase in motivation to engage in mental health treatment as
measured by the Motivation to Engage in Therapy Questionnaire posttest
(MET posttest), FMP, and Credibility/expectancy questionnaires, compared
to the enhanced consultation interview group.

HA: Patients receiving the enhanced consultation interview will show a
significant increase in motivation to engage in mental health treatment as
measured by the Motivation to Engage in Therapy Questionnaire posttest
(MET posttest), FMP, and Credibility/expectancy questionnaires compared to
the care as usual consultation interview group.
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2. To what extent will demographic variables (i.e., age, gender, employment status,
etc.) and severity of symptoms be associated with increased motivation to engage in
mental health treatment?
To further enhance this study, a newly developed Motivation to Engage in
Therapy questionnaire (MET) was designed to examine specific issues which
influence motivation but are not addressed in the other measurements. Additionally,
the psychometric properties of this newly developed questionnaire were evaluated
for internal consistency and validity. Although the FMP has been well documented
as a valid measure in European countries, its psychometric properties with this
sample of U.S. participants were also evaluated for the two subscales that were of
most interest to this study (PTE and OP).
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CHAPTER 4: METHODOLOGY
The primary aim of this study was to evaluate the impact of an analogue
enhanced consultation interview (between the physician and patient with
somatization) on patient’s motivation to engage in mental health therapy along with
medical care.
Design
As shown in Figure 3, the study used an experimental group pre-post design.
Patients with somatization were randomly assigned to one of two conditions: (1)
consultation as usual or (2) enhanced consultation (Appendices J and K).
___________________________________________________________________
SOMS-7, FMP (PTE, OP Subscales), Credibility, Expectancy Subscales, and
demographic questions
R

O

X (consultation interview as usual)

O

R

O

X (enhanced consultation interview)

O

Note: Patients were assessed with The Motivation to Engage in Therapy
Questionnaire (MET) was given as a pre and posttest (MET-pretest and METposttest). The pretest was conducted over the phone.
____________________________________________________________________
Figure 3. Overview of design.
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Assessed for eligibility (n=153 )

Excluded (n= 11 )
♦ Not meeting inclusion
criteria (n= 7 )
♦ Declined to participate
(n= 4)

Randomized (n=142)

ENHANCED
INTERVIEW
Allocated and received to
intervention (n=68)

CONTROL
INTERVIEW
Allocated and received
intervention (n=74)

Lost to follow-up (n= 5)

Lost to follow-up (n=8)

Failed to mail the second portion of
study

Failed to mail the second portion of
study

Analysed (n= 63)

Analysed (n=66 )

Figure 4.

Participant Flow Diagram
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Sample
A power analysis was conducted to determine how many participants would
be needed to provide the study with a reasonable chance of obtaining statistical
significance among the two groups. A sample size analysis indicated that the
hypothesized effect size between the analogue enhanced consultation interview and
the analogue care as usual consultation interview groups, assuming .40-medium
dispersion for the two means and an average correlation between the covariate:
MET-pretest and the motivation questionnaires: MET-posttest, Credibility,
Expectancy subscales and, PTE and OP subscales) of .40. Applying these
assumptions indicated approximately 65 participants would be required per group
(total N= 130) to provide an 87% or greater chance of obtaining a statistically
significance at the .05 level for the overall ANCOVA F-ratio (Bausell & Li, 2002).
Participants were recruited between March and September 2009 from several
venues throughout the Northwest (See Figure 4. Patient Flow Chart). Distributions of
flyers were posted in general medical practices throughout Oregon (Appendix B).
Along with the flyer, letters were sent to medical providers notifying them of the
nature, purpose and timeline of the study, as well as a request for permission to post
a patient recruitment flyer in their offices (Appendix C). Additionally, individuals
were recruited by placing ads on Craigs List (Appendix D), and in news magazines
and newsletters throughout the Northwest (Appendix E).
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Individuals included in the study were between the ages 18 and 65 who had
at least two medically unexplained physical symptoms that persisted for the prior 6
months. Participant inclusion criteria were relaxed in comparison to the stricter
criteria of somatization in order to capture a wider net of the more typical and
problematic presentations represented in primary care. This broader definition of
somatization is slightly more stringent than that of the DSM-IV - diagnosis of
undifferentiated somatoform and the definition has been used in more recent studies
such as Martin, Rauh, Fichter, and Rief (2007). Participants were excluded if they
were actively being treated for a disease that produced physical symptoms (e.g.,
cancer).
One hundred and fifty-three individuals were screened for the study before
acquiring the recommended total of 129 participants. Seven individuals failed to
meet the eligibility criteria, four individuals thought the study would take too much
time and decided not to participate, and 13 participants enrolled in the study did not
complete the second assessment and were replaced by additional individuals
recruited to the study. Moreover, it was later discovered that one of the 129
participants was 70 years of age. However, this case had a negligible effect on the
results and was included in the final analyses. The total number of participants in the
control group and experimental groups were 66 and 63 respectively. While
participants were given the choice to complete the study questionnaires by email or
regular mail, 87% of them chose to use regular mail.
79

Demographic characteristics. The socio-demographic characteristics of the
two groups are presented in Table 1. Participants were predominately non-Hispanic
white, women, married or divorced, approximately 45 years of age, and with
incomes below $25,000. These characteristics are similar to other studies examining
somatization (Hiller, Rief, & Brahler, 2006).

Measures
Symptom Measures
The Screening for Somatoform Disorders (SOMS-7) was used to examine the
number and severity of medically unexplained symptoms. It is a self-report measure
which draws 53 items from the DSM-IV and ICD-10, requiring the respondent to
rate the number and severity of each somatization symptom that is medically
unexplained on a 5-point scale (Rief & Hiller, 2003). The SOMS-7 has good internal
consistency reliability (alpha= .92) and adequate test-retest reliability coefficients
(.71-.76). This scale is superior to others as it assesses medically unexplained
symptoms as compared to medically explained symptoms. There are 52 items for
women and 48 for men rated on a 5-point scale from 0=not at all to 5=very severe
(Appendix F). Summed items determine the score for number of symptoms and
summed scores are totaled to determine the severity. Although the scale originated in
Germany, it has been applied to studies in several different countries.
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Also included in this study was a demographic questionnaire composed of
items used by many other researchers (e.g., Timmer, Bleichhardt, & Rief, 2006;
Schweickhardt, Larish, Wirsching, & Fritzsche, 2007) (Appendix G).
Motivation for Therapy Measures
To assess the underlying dimensions of motivation for therapy for those with
somatization who present to primary care for treatment, this study employed
measures which reflected central factors thought to have a direct bearing on
physician-patient interaction, both verbally and non verbally (Schneider & Klauer,
2001). These included the FMP, the Credibility/Expectancy and the (MET)
questionnaires.
The FMP assesses patient’s attitudes towards their somatic problems and
their motivation for psychotherapy (Schneider, et al., 1989; Schneider & Klauer,
2001). This self-report instrument contains 47 items, rated on a 5-point scale
(1=completely agree to 5= completely disagree (Appendix H). There are 4 subscales
with high scores reflecting more agreement with each of the following dimensions.
The degree of psychotherapy motivation is the summed scores for each of the 4
subscales. The first two subscales measure illness attitudes. The Negative illness
consequences (NIC) subscale consists of affective components measuring the
amount of strain imposed by suffering, burden of suffering, consequences and
secondary illness benefits. (e.g., “My outlook with regard to my condition is mostly
optimistic.”). Higher scores reflect a stronger perception of suffering. The
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Psychological lay expectations (PLE) subscale measures the patient’s view and
assumptions about the underlying cause of their illness and the degree of
psychosocial vs. somatic illness attributions (e.g., “As of late, my condition is
actually of a physical origin.”). Higher scores indicate stronger psychological
attribution for symptoms. The third scale: Psychotherapeutic treatment expectation
scale (PTE) measures general expectation and attitudes about the functional value of
physical vs. psychotherapeutic treatment – patient’s ideas and anticipation of somatic
over psychotherapeutic approaches to treatment (e.g., “True relaxation would help
me more than any psychological treatment.”). The higher the score, the more
positive attitude towards and favorable expectations of psychological treatment over
physical treatment. The fourth scale, Openness to psychotherapy (OP) measures
attitudes and experience about therapy - past and current, personal and vicarious. It
also measures assumptions and general readiness to engage in therapy (e.g., “With
help from psychological treatment, I can learn to better understand my physical
afflictions, too.”). Higher scores indicate generally favorable attitudes for
psychological treatment.
The FMP is a questionnaire with four subscales and developed in Europe in
German language. Each of the subscales has strong internal consistency reliability
(Cronbach’s alpha of .71-.86) and retest reliability from .67 to .96 (Schneider et al.,
1989). This scale has been used in both inpatient and outpatient mental health
settings for patients with somatization. This instrument was tested in German
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speaking countries with a different language and cultural and racial makeup from the
U.S. The potential limitations and trade-offs for including this instrument in the
study were carefully weighed. The strength of this instrument, which lies in its
ability to assess individuals with somatization, was anticipated to provide more
benefit than costs. This instrument was translated into English by a professional
translator with the American Translators Association and its psychometric properties
were evaluated for this country in the current study.
A reliability analysis was conducted on the FMP to examine the internal
consistency of the scales for English speaking participants. Cronbach’s alpha was
computed for each of the 4 separate subscales: NIC Scale= Cronbach’s α=.710;
PLE= Cronbach’s α=.700; PTE= Cronbach’s α=.648; and OP= Cronbach’s α=.781.
A reliability estimate of Cronbach’s alpha of .70 or higher is associated with high
degree of consistency in scores among equivalent items. The reliability estimates
were similar to those found in Schneider and Klauer (2001).
The Credibility Expectancy Questionnaire Version II consists of 6
statements regarding thoughts and feelings about the usefulness of therapy (Devilly
& Borkvec, 2000). Each statement is rated using a 9-point Likert scale from 1 - none
at all to 9 - very logical, useful (Appendix I). The instrument is divided into two
subscales: Credibility and Expectancy. Statements assessing credibility are contained
in the first three questions and expectancy is derived from the last three statements.
Scores were summed for each subscale and then standardized due to the use of two
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different scoring methods for the subscale of expectancy. This instrument had been
previously shown to have strong internal consistency and test-retest reliability. The
credibility subscale had Cronbach’s α of between .81 and .86 and the expectancy
subscale had a Cronbach’s α of between .79 and .90. Inter-item correlation across
studies ranged from between .53 and .85 for the expectancy subscale and .62 and .78
for the credibility subscale. Test-retest reliability for expectancy and credibility
subscales were .82 and .75, respectively. This scale measures how motivated
individuals would be to participate in therapy, based on how credible they believe
the therapy would be and what they expected from the therapy. This instrument was
included in this study because it was thought to add additional information about the
relationship between the effects of motivation and the experimental group, and to
help validate the FMP instrument.
While both instruments, the FMP and Credibility/Expectancy questionnaires,
examined the extent to which several factors are important in the consultation
process in order to motivate individuals to engage in therapy, each presented a
different set of limitations. First, while many of the issues thought to bear on
motivation for those with somatization to engage in therapy are measured in the
FMP, the instrument heretofore had not been tested in the U.S. population. Second,
although the psychometric properties of the Credibility/Expectancy measure have
been shown to be quite reliable, this instrument, as well as the FMP, lacked
comprehensive coverage of other elements thought to influence motivation for
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engaging in mental health treatment, such as cognitive dissonance, medical provider
abandonment, timing, and counselor proximity.
Motivation to Engage in Therapy Questionnaire (MET)
The Motivation to Engage in Therapy Questionnaire (MET) was developed
to measure elements thought to influence motivation to engage in therapy from the
literature review. Composed of 12 items with ratings on a 5-point Likert scale, this
instrument was used both as a pretest (Appendix J) and posttest (Appendix K).
Examples of some of the questions include the following: “I believe that whether my
symptoms are caused by physical or emotional reasons, I need to get help for both”.
“If my doctor recommended adding counseling to my treatment plan, I would feel
that the doctor is looking for a way to get rid of me”. “I worry that if I go to
counseling my doctor will think that I don’t need medical care”. The reliability of
the MET was evaluated for internal consistency reliability and yielded a strong
Cronbach’s alpha of .834. This coefficient represents the homogeneity of the
measure or consistency across items. In other words, it examines the degree to which
all the items measure the same underlying construct.

Analogue Interventions
Prior to the study, an expert panel consisting of 7 medical providers was
asked to rate how much they agreed with 5 statements (using a 5- point Likert scale)
about the care as usual consultation interview vignette to evaluate whether elements
85

included represented a typical consultation (Appendix L). The expert panel also rated
the enhanced consultation interview to asses whether differences between the two
conditions were evident. Based on feedback from this panel, changes in both the care
as usual and enhanced interviews were integrated into the following vignettes.
Control Consultation Interview Condition.
The literature provides support for a care-as-usual comparison group, based
on the patient centered and attribution model by Goldberg, Gask, & O'Dowd (1989).
Elements such as active listening, eliciting illness expectations, linking physical and
emotional causes, eliminating blame, providing information and suggestions about
treatment options, and negotiating treatment goals have been shown to facilitate
positive interactions between patient and physician and engender patient satisfaction
(Smith, et al., 2006; Moriss, et al., 2007). However, it suggests more of a “gold
standard” and it is neither fully nor typically practiced in primary care (Hartz, Noyes,
Bentler, Damiano, Willard, & Momany, 2000). After consulting with the expert
panel, the control condition was modified to include elicitation of subjective
complaints and illness expectations; linking physical and emotional causes, and
providing empathy (Appendix M).
Enhanced consultation interview.
While the enhanced interview condition incorporates the tenets of the
reattribution model which has been suggested for consultation between primary care
providers and patient, it goes beyond to integrate the elements associated with
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motivating patients towards successful referral to mental health treatment. These
include the following: 1) Anticipating the need for therapy (e.g., the introduction to
mental health therapy during the consultation; 2) Linking of emotional and physical
components of health. This integration was accomplished by explaining the
interrelatedness of emotional stress and physical symptoms while also
acknowledging that either element may come first or be more important than the
other; 3) Emphasizing optimal treatment which includes both medical care and
mental health therapy. This entailed discussing the benefit of treating both the
emotional and physical impact simultaneously rather than on the basis of the
exclusion process; 4) Dispelling myths or erroneous assumptions that patients
sometimes have about counseling. For example, counseling was described to address
the stress of patients with unexplained physical symptoms; 5) Establishing how the
provider will remain involved in the patient’s care (e.g., it was underscored how the
patient’s physical symptoms would be continued to be monitored by the medical
provider; and 6) Providing ease of referral process (e.g., endorsing and introducing a
therapist) (Appendix N).
Procedures
Flyer
The flyer and the advertisements described the purpose of the study: how
providers could help patients deal with the stress of having medically unexplained
physical symptoms in order to assist both medical and mental health providers to
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better understand what is needed to help improve care. Also described were the
criteria for participation, compensation and contact information for the investigator.
Patients who wanted to enroll in the study were asked to contact the number on the
flyer and leave their contact information either in voice mail or by email.
Informed Consent, Screening, and Pretest
For those individuals who contacted the researcher via the telephone number
provided on the flyer, the researcher responded with a telephone script (Appendix
O). The researcher first explained the purpose of the study including the eligibility.
Participants who continued to show interest and believed they were eligible were
next read the consent form (Appendix P). For those participants who agreed to give
verbal consent, the researcher documented consent by signing and dating the consent
form. The researcher next verified eligibility. Once eligibility was established, the
participant was asked to complete the MET, which was read and the participant’s
responses documented by the researcher. The researcher next explained that the
participant had two ways to complete and return the materials for the second portion
of the study. 1) The questionnaires could be mailed by the researcher and completed
and returned by the participant (with a pre addressed stamped envelope), or 2) The
questionnaires could be sent by email and the participant could save the
questionnaires, complete the questionnaires, and email them back to the researcher.
After participants indicated a preference for completing the study, they were
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randomly assigned to one of two conditions: 1) care as usual consultation interview
vignette or 2) enhanced consultation interview vignette.
Vignette Administration and Posttest
To facilitate the vignette administration and posttest portions of the study, the
researcher provided the participants with the following materials: Instruction Form
(Appendix Q), Community Resource Sheet (Appendix R), SOMS-7, one of two
vignettes depending on the randomization of the conditions), MET-posttest), FMP,
Credibility/Expectancy, and demographic questionnaires.
The entire process (including the initial contact) took approximately one
hour. The participant was informed that upon receipt of the completed study
materials, the researcher would send or give directly to the participant a check for
$50. This was accompanied by a thank you note (Appendix S).
Analysis
Dependent Variable
Motivation to engage in mental health treatment was evaluated with 3
outcome variables: a newly developed Motivation to Engage in Therapy
questionnaire (MET-pretest), Credibility and Expectancy subscales, and FMP
subscales, Psychotherapeutic Treatment Expectations (PTE) and Openness to
Psychotherapy (OP).
Independent Variable
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Type of condition (care as usual consultation interview or enhanced
consultation interview)
Co-variate
Motivation to engage in therapy (MET) pretest questionnaire

Group differences were tested with chi-square analysis for frequencies and ttests for means. In the correlation analyses, Pearson’s coefficient was computed.
Separate analyses of covariance were performed for each motivation measure (METposttest, Credibility, Expectancy, and PTE subscale revised for outliers; and OP
subscale revised for missing data). There was a very small percentage of missing
values for all outcome measures (less than 2%) with the exception of two questions
on the OP subscale, #8 and #42. The number of participants not responding to these
two questions was 24% and 16%, respectively. Completion of the latter question was
optional. The total number of unanswered questions for the two questions on the OP
subscale was problematic and these questions were removed from the summed scale.
Therefore, the number of subjects varied slightly for different measures. The
variable: SOMS-7, which was highly skewed; in both number and intensity, was
transformed using a square root transformation. The skewness of this measure was
also noted in another study (Timmer, et al., 2006). Outliers were removed for the
following univariate variables: education (two PhDs participants had beyond 26
years of education) and age (one respondent was 70) for univariate analyses,
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however they were retained for multivariate analyses as they had negligible effects
on the results. For the FMP (PTE) subscale, one outlier was removed.
Assumptions
ANCOVA assumptions were first evaluated. The reliability of the covariate
(MET-pretest) yielded a Cronbach’s alpha of .770, which suggests that the pretest
measure had strong internal consistency reliability. An evaluation of the correlation
between the covariate (MET-pretest) and dependent measure (MET-posttest) yielded
a coefficient of .690, which was well above the recommended .40. The correlation
between the MET-pretest and Credibility scale also was above .40 (.43). The
correlation between the MET-posttest and the Expectancy scale, the FMP subscales
PTE and OP were slightly below .4 (.375, .393, and .373).
For multivariate analyses, outliers were examined by first computing a
Mahalanobis Distance for each case, and then tested using a chi-square distribution,
with a conservative value of alpha (p < .001). One case was identified and the
analyses were rerun with the deleted case. Distributions for each group were
examined for skewness and kurtosis and shown to be within normal limits after
deletion of the outlier. Deletion of this case resulted in negligible effects for all
outcome measures; therefore, the data were retained in the ANCOVA analyses.
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CHAPTER FIVE: RESULTS
The sociodemographic characteristics of the two groups are shown in
Table 1. Group comparisons were evaluated with t-test and chi-square (χ²). Due to
multiple categories for race, marital status and diagnosis, these sociodemograpic
variables were first dichotomized (highest percentage category with all other
categories) in order to compute χ². The care as usual consultation interview group
and enhanced consultation interview groups differed with regard to two sociodemographic factors. The analogue enhanced consultation interview group scored
significantly higher than the care as usual consultation interview group on working
part-time χ² [1] = 6.17, p =.027 and perceiving counseling as positive (χ², 1) = 5.096,
p <.05). Upon further examination of these two variables, between group differences
remained significant for only those who found counseling positive and the FMP (OP)
subscale. In general, findings were not better explained by these unexpected
differences in groups.
Validity of Measures
The validity of the MET scale was evaluated with a principle components
analysis to identify and compute composite motivation scores for factors thought to
underlie the scale. Results of the factor analysis suggest plausible one and two factor
solutions. A stronger first factor with higher loading on seven items tapping doctororiented dimension and a weaker second factor with three items tapping patientoriented dimension were found. Based on statistical considerations (low factor
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saturation of the second factor) and the single factor tapping both doctor and patientoriented dimensions, the single factor solution was retained. Reliability analyses
showed strong reliability coefficients for the single factor solution and a moderate
reliability coefficient for the second factor (alphas of .86 and .71 respectively). Table
2 shows the correlation matrix for the MTF-posttest and Table 3 shows loadings for
each item in the MTF scale for a one factor solution. The loadings show the
correlation between each item with the one factor and suggest those items that cluster
together. All of the items have fairly strong loadings on one overall factor except
item 12. The total variance explained by the single factor is 38.5%.
Table 4 shows zero-order correlations between all the motivation scales. The
MET-posttest was highly correlated with Credibility and moderately correlated with
Expectancy subscales (.652 and .497) which provided support for convergent
validity. Those respondents that scored high on motivation for the MET-posttest
measure were associated with higher scores on how credible they anticipated therapy
would be. And, to a slightly lesser extent those respondents that scored high on
motivation for the MET scored higher on how much improvement in symptoms they
expected. Also noteworthy were moderate to strong correlations between the METposttest and PTE subscale revised and OP subscale revised. Those respondents that
scored high on the MET-posttest had more favorable expectations for psychological
therapy over physical care and openness to therapy.
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Convergent validity was also demonstrated for the FMP (PTE) and (OP)
subscales. There were significant and strong correlations between the PTE and the
Credibility and Expectancy subscales (r=.388 and .443). The OP subscale also was
strongly correlated with the Credibility and Expectancy subscales (r=.556 and .430).
Higher scores for openness to psychotherapy were correlated with higher scores on
the perceptions of credibility for therapy and greater expectancy of what therapy
could accomplish.
While the FMP (NIC) subscale and FMP (PLE) subscales were not the focus
of this study, it is interesting that the (PLE) subscale was moderately associated with
most of the motivation scales and highly correlated with Expectancy scale. Higher
scores on the (PLE) subscale reflect higher scores for psychological attribution of
symptoms. In general, participants who had stronger psychological attribution for
their symptoms were more motivated to participate in therapy. These findings are
consistent with others: Speckens et al., 1995; Schneider and Klauer (2001).
Research Hypothesis and Questions
The study hypothesized that patients receiving the analogue enhanced
consultation interview would show increased motivation to engage in mental health
treatment as compared to patients receiving the analogue care as usual consultation
interview. This research hypothesis was supported for 4 of the 5 dependent measures
(MET-posttest; and the Credibility, Expectancy, and FMP (OP) subscales). After
adjusting for the covariate, there were significant differences between the two
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analogue consultation conditions for these outcome measures: The largest effects
were found for MET-posttest [F (1.126) =19.18, p =.000, Cohen’s d = 1.6], and the
FMP (OP) revised subscale [F (1,123) =8.64, p=.004, Cohen’s d = 1.6]. Also
demonstrating strong effect sizes were the Credibility scale, [F (1,125) =18.75, p=.
000, Cohen’s d=.9] and Expectancy scale, [F (1,123) =6.98, p =.009, Cohen’s d=.8].
Table 5 shows the results of all ANCOVA’s.
There was a significant mean difference between the two interview
conditions on the MET-posttest, p< .001 with a large effect size of 1.6. This finding
demonstrates that those in the care as usual interview group scored 4.5 points lower
on the MET-posttest than those in the enhanced consultation interview group. This
can also be interpreted as indicating the average participant in the enhanced
interview consultation condition was more motivated to engage in therapy than
94.5% of the participants in the care as usual condition.
The mean difference between the two analogue interview conditions on the
Credibility subscale also was significant, p< .001 with a large effect size of .9. There
was a 1.8 point difference between care as usual interview group on the Credibility
subscale compared to those in the enhanced interview consultation interview. In
other words, the average participant in the enhanced interview consultation found
therapy to be a more credible option than 82% of those in the care as usual condition.
Likewise, the Expectancy subscale demonstrated a significant mean
difference between the two interview conditions, p< .01 with a large effect size of .8.
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Those in the care as usual interview group scored 1.3 points lower on the Expectancy
subscale than those in the enhanced interview consultation interview group. Thus,
the average participant in the enhanced interview condition was more motivated to
engage in therapy than 79% of the participants in the care as usual condition.
Finally, there was a significant mean difference between the two interview
conditions on the FMP (OP) subscale, p< .01 with a large effect size of 1.6. Those in
the care as usual interview group scored 5.3 points lower on the FMP(OP) subscale
than those in the enhanced interview consultation interview group. For the FMP (OP)
subscale, the average participant in the enhanced condition was more open to
participating in therapy than 94.5% of the participants in the care as usual condition
to engage in therapy.
Research Question 2: To what extent are demographic variables and severity of
symptoms associated with increased motivation to engage in mental health
treatment?
The relationships between the socio-demographic variables and the
motivation scales were examined using Pearson product-moment correlation
coefficient. The socio-demographic variables associated with motivation for therapy
included education, prior counseling, current counseling and positive counseling
experiences. There were small but positive correlations found between education and
the Credibility subscale (r = .18, N = 126, p <.05) and between prior counseling and
the Credibility scale (r =.22, N=127, p< .05). Those participants with higher levels of
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education and prior counseling had higher scores on the perceived credibility. A
significant moderate positive relationship between was found between those in
current counseling and the FMP (OP) subscale (r=.315, N = 123, p <.01). Those
participants currently participating in counseling had higher scores on the FMP (OP)
subscale. A small, negative correlation was found between negative counseling
experience and MET-posttest (r=-.22, N=98, p<.05), credibility (r=-.29, N= 97,
p<.05), and expectancy (r=-.28, N=95, p <.05); and a moderate correlation was found
between negative counseling experience and the FMP (OP) subscale (r=-.38, N=97,
p<.05). Those who had negative counseling experiences exhibited lower levels of
motivation on these scales. Interestingly, there were no associations found between
the number or intensity of physical symptoms with any of the motivation scales.
Additional correlation analyses further examined whether the relationship
between demographic variables and motivation (for each outcome measure) differed
between the care as usual and enhanced conditions. There was a significant positive
relationship for education and motivation on the Credibility subscale for the
enhanced condition (r=.30, N=60, p<.05) and a significant positive correlation
between prior counseling and motivation on the Credibility subscale for the
enhanced condition r=.34, N=64, p<.01.These significant correlations were further
investigated in a regression analysis. While controlling for the covariate, METpretest, the relationships between the demographic variables and motivation on the
Credibility scale did not reach significance across the two conditions.
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Post hoc Analysis to Control for Positive Counseling Experiences
Because the groups differed with regard to scores on perceiving counseling as
a positive experience and part time employment, the main outcome measures were
reanalyzed, controlling for these variables along with the covariate (MET-pretest)
and type of intervention. The regression analysis for positive counseling experiences
supported the same pattern of results for ANCOVA’s with the exception of the
FMP(OP) subscale which demonstrated a non-significant trend relationship between
the enhanced consultation and positive counseling experiences, F (3, 91) =12.02, p=
.08. The regression analysis for part time employment supported the same pattern of
results for all ANCOVA’s. In general, the results held, and were not better accounted
for by the sample heterogeneity.
A supplemental regression analysis was conducted to further examine
whether participants who scored high or low on the MET-pretest or scored high or
low on negative counseling experiences responded differently to the type of
intervention for each outcome measure. All the motivation measures were regressed
on the MET-pretest, the enhanced interview condition, the interaction between the
interaction between MET-pretest and the enhanced condition, and finally the
interaction between negative counseling experience and the enhanced condition. All
variables were centered to control for multicolleniarity which was introduced by the
interaction terms. Findings demonstrated that participants scored differently to the
type of intervention on both the MET and Credibility subscale when the covariates of
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the MET-pretest and previous counseling experiences were further examined. Table
6 shows the results from investigating these covariates and their interactions
considered to have an effect on these two motivation scales.
There was a statistically significant interaction between negative counseling
experience and the enhanced consultation interview for the MET-posttest, t (92) =
2.574, p<.05. R2 =.57. Additionally, there was a trend–level relationship for negative
counseling experience and the enhanced consultation interview for the Credibility
subscale, t (91) =-1.943, p=.055). R2 =.61. This result suggests that the relationship
between enhanced consultation condition and the MET-posttest was moderated by
those with previously negative counseling experiences. In other words, while
controlling for the stronger positive effect of the enhanced consultation interview,
those with previously negative counseling experiences were less favorable (scored
lower) towards therapy on the MET-posttest measure and to a lesser extent the
Credibility scale.
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Table 1
Descriptives for sociodemographic characteristics. N =129
__________________________________________________________________________
p
Care as usual n=66
Enhanced n=63
Mean
Mean
___________________________________________________________________________
Age (mean)

45

46

NS
χ²
NS

Gender
Female
Male

48
18

Education (mean)

Race
American Indian
Hawaiian or other
Pacific Islander
Asian
Black or African
American
Hispanic or
Latino
Non-Hispanic
White
Other

(72.2)
(27.2)
13.78

44
19

(69.0)
(30.1)

t
NS

14.59

χ²
NS a
1

(1.5)

1

(1.5)

3
1
5

(4.5)
(1.5)
(7.5)

0
1
3

(.0)
(1.5)
(4.7)

0

(.0)

1

(.8)

51
5

(77.2)
(7.5)

53
4

(84.1)
(6.3)
χ²
NSb

Marital
Single
Married
Divorced
Widowed
Separated
Never Married
Member of unmarried couple

6
14
19
7
3
10

(9.0)
(21.2)
(10.6)
(10.6)
(4.5)
(15.1)

6
14
13
4
3
3

(4.7)
(9.5)
(20.6)
(6.3)
(4.7)
(20.6)

7

(10.6)

10

(15.8)

Working full-time

10

(15.1)

19

(30.1)

Working part time
Unemployed

16
40

(24.2)
(60.6)

8
35

(12.6)
(55.5)

Employment

χ² [1]= 6.17, p =.027
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Disabled
Yes
No

36
30

(54.5)
(45.4)

23
40

(36.5)
(63.4)

χ²
NS

Income
<$25,000
$25,000 to <$70,000
$70,000 or more

49
14
3

(74.2)
(21.2)
(45.4)

41
15
7

(65.0)
(23.8)
(11.1)

51
12

(80.9)
(19.0)

Prior Counseling
Yes
No

49
16

(74.2)
(25.3)

Counseling Helpful
Yes
No

χ²
NS
NS
χ²
NS c

Diagnosis
Anxiety
Depression
Bipolar
PTSD
Other
More than one diag.
Personality Disorder

χ²
NS

3
6
2
4
1
4
1

(4.5)
(9.0)
(3.0)
(6.0)
(1.5)
(6.0)
(1.5)

0
4
2
4
1
8
0

32
26

(48.4)
(39.3)

43 (68.2)
7 (11.1)

(.0)
(6.3)
(3.1)
(6.3)
(1.5)
(12.6)
(.0)
χ² [1]= 5.096, p< .05

χ²
Current Counseling
NS
Yes
17
(25.7)
11
(17.4)
No
45
(68.1)
51
(80.9)
________________________________________________________________________
a
Race was dichotomized into two groups to examine group differences for the category with highest
percentage (White) and all other categories
b
Marital status was dichotomized into two groups to examine group differences for the category with
highest percentage (Divorced) and all other categories
c
Diagnosis was dichotomized into two groups to examine group differences for the category with
highest percentage (More than one diagnoses) and all other categories
Values are number of participants with percentages in parentheses.
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Table 2.

Correlation Matrix for MET Posttest Scale

______________________________________________________________________________________________________________
1
2
3
4
5
6
7
8
9
10
11
12
______________________________________________________________________________________________________________
Item 1 1.000
Item 2 .258**
1.000
Item 3 .223*
.324**
1.000
Item 4 .178*
.175*
.299**
1.000
Item 5 .066
.323**
.239**
.273**
1.000
Item 6 .232**
.590**
.389**
.243**
.414**
1.000
Item 7 .304**
.411**
.130
.187*
.314**
.508** 1.000
Item 8 .183*
.252**
.494**
.595**
.193*
.338**
.178* 1.000
Item 9 .215*
.600**
.310**
.304**
.360**
.617**
.435** .329** 1.000
Item 10 .214*
.557**
.362**
.275**
.347**
.604**
.405** .383** .831** 1.000
Item 11 .125
.339**
.320**
.344**
.166
.467**
.391** .338** .503** .496** 1.000
Item 12 -.069
-.030
.201*
.112
-.041
.059
.081
.120
-.102
-.048
.109 1.000
______________________________________________________________________________________________________________
** Pearson r correlation coefficient is significant at the 0.01 level (2-tailed).
* Pearson r correlation coefficient is significant is significant at the 0.05 level (2-tailed).
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Table 3
Factor loadings based on a principle components analysis with one factor solution for MET
________________________________________________________________________________________________________________
Component Factor
________________________________________________________________________________________________________________
1. The only way my physical symptoms will get better is obtaining medical care.
.371
2. If my doctor recommends that I go to counseling for my physical symptoms, it probably means that the doctor thinks
my symptoms are all my head.
.711
3. I have a good understanding of how counseling can help with my physical symptoms.
.565
4. I believe that whether my symptoms are caused by physical or emotional reasons, I need to get help for both.
.515
5. I wouldn’t go to counseling because the process of finding a counselor is difficult.
.512
6. If my doctor recommended adding counseling to my treatment plan, I would feel that the doctor is looking for
a way to get rid of me.
.797
7. If my doctor suggested adding counseling to the treatment plan, I would not feel that the doctor believes I have a
physical problem.
.607
8. Counseling is just as important as medical care for helping me cope with my physical symptoms.
.587
9. I worry that if I go to counseling, my doctor will think that I don’t need medical care.
.823
10. If I went to counseling, it might suggest to my medical providers that my physical problems don’t really exist.
.818
11. If my doctor suggested that counseling be added to the treatment plan, I would feel that my needs are being respected.
.654
12. I would be more likely to go to counseling if it was available in the same building as my doctor.
.061
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Table 4
Correlations among MET-posttest, FMP subscales, Credibility and Expectancy subscales
_____________________________________________________________________________________________
1
2
3
4
5
6
7
_____________________________________________________________________________________________
1. MET12-posttest
2. NIC subscale
-.0253. PLE subscale
.302**
.225*
4. PTE3revised
.434**
.074
.456**
5. OP revised
.525**
.189*
.360**
.397**
6. Credibility
.652**
.127
.451**
.388**
.556**
7. Expectancy
.497**
.137
.507**
.443**
.430**
.735**
______________________________________________________________________________________________
N=129. MET-posttest=post motivation to engage questionnaire; FMP1 subscale= Negative illness consequences
(NIC); FMP2 subscale =Psychological Lay etiology (PLE); FMP3 subscale =Psychotherapeutic Treatment
Expectations (PTE); and FMP4 subscale=Openness to Psychotherapy (OP); Credibility =the subscale of
Credibility/Expectancy Scale; Expectancy = subscale of Credibility/Expectancy Scale.
** Pearson r correlation coefficient is significant at the 0.01 level (2-tailed).
* Pearson r correlation coefficient is significant is significant at the 0.05 level (2-tailed
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Table 5
Analysis of Covariance for Outcome Measures
Comparison of Analogue Care as Usual Consultation Interview and Analogue Enhanced Consultation Interview
____________________________________________________________________________________________________________
Care as Usual
Enhanced
Mean
SD
SE
95% C.I.
Mean
SD
SE
95% C.I.
F
Cohen’s d
____________________________________________________________________________________________________________
MET-posttest
38.56

8.31

.683

37.21

39.91

42.98

7.36

2.39

.282

-1.416

-.299

.899

2.69

-.595

2.62

.320

-1.228

.039

.622

63.18

9.84

1.235

60.74

65.63

68.23

.699

41.46

44.23

19.18***

1.6

.291

.323

1.475

18.75***

.9

2.91

.330

-.032

1.277

6.98**

.8

10.97

1.235

65.87

70.76

8.64**

1.6

Credibility Scale
-.857

Expectancy Scale

OP Scale
___________________________________________________________________________________________
MET-posttest=post motivation to engage questionnaire; Credibility = subscale of Credibility/Expectancy Scale;
Expectancy = subscale of Credibility/Expectancy Scale; FMP (OP) = Openness to Psychotherapy (OP).
Care as Usual =analogue control condition; Enhanced =analogue experimental condition.
*
p <.05. **p < .01. ***p < 0.001.
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Table 6
Regression analysis for interaction terms controlling for positive effect of the enhanced consultation condition
on the MET and Credibility measures.
________________________________________________________________________________________
Dependent Variable
B
SE
P
________________________________________________________________________________________
MET posttest
MET pretest
.705***
.104
.000
Enhanced
.316***
1.260
.000
Negative counseling experiences
-.008
1.694
.931
MET pretest x enhanced
-.093
.555
.321
Negative counseling experiences x enhanced
-.230*
2.770
.012
Credibility
MET pretest
.358**
.042
.002
Enhanced
.370***
.514
.000
Negative counseling experiences
-.068
.668
.523
MET pretest x enhanced
.068
.064
.544
Negative counseling experiences x enhanced
-.212+
1.126
.055
_______________________________________________________________________________________
MET posttest (MET posttest motivation to engage in therapy questionnaire)
MET pretest (MET-pretest motivation to engage in therapy questionnaire)
Condition- type of intervention (analogue care as usual consultation interview vs. analogue enhanced consultation
interview)
+
p <.10 trend. *p < .05. **p < 0.01. ***p<.001
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CHAPTER SIX: DISCUSSION
The focus of this study was to examine whether an enhanced medical
consultation interview would be superior to a care as usual consultation interview in
increasing the motivation of individuals with somatization to engage in psychological
therapy along with their medical care. Overall, there were significant differences
between the two analogue interventions - the care as usual and enhanced consultation
interviews - on 4 of the 5 motivation scales. Main effects for MET-posttest,
Credibility, Expectancy and the FMP4 (OP) subscales demonstrated large effect sizes:
Cohen’s d =1.6, .9, .8, and 1.6 respectively.
These findings may be due, in part, to the inclusion of content in the enhanced
analogue intervention vignette that had been advanced by different investigators as
having potential to motivate individuals to engage in mental health therapy. However,
none of these elements had been specifically tested. For example, Looper and
Kirmayer (2002) suggested that the provision of psychotherapy in the context of a
medical setting is more consistent with a patient’s view of care and therefore is an
acceptable option. Bakal, et al. (2006) and Speckens et al. (1995) argued that
motivation for somatizing patients to engage in therapy may be improved by reducing
the patients’ fear of abandonment by their doctor. In a study by Martin, Rauh, Fichter,
and Rief (2007), the rationale for participation in mental health therapy was described
as the benefit which augments coping skills for physical symptoms (instead of
searching for psychological causes of symptoms), resulting in high levels of patient
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acceptance for counseling. Integrating the components informed by previous studies
into an analogue consultation demonstrated that the discourse of the enhanced vignette
was, indeed, more successful for motivating individuals for counseling than the care as
usual vignette.
That the FMP (PTE) measure was not significant as a main effect could be due
to statements in this scale which reflect comparisons between physical and
psychological treatment. Statements such as “True relaxation would help me more
than psychological treatment” or “I am better off with a physician than a
psychotherapist with regard to my condition” show that the scale measures attitudes
and expectations about the value of physical treatment over psychological treatment.
This is in contrast to the MET-posttest measure which didn’t include comparisons and
thus require participants to choose one treatment over the other. Rather, the statements
were characterized by a unilateral statement (e.g., “The only way my symptoms will
improve is with medical care.”) or they reflected the idea of “adding” both physical
and psychological treatment together (e.g., “I believe that whether my symptoms are
caused by physical or emotional reasons, I need to get help for both” or “If my doctor
suggested that counseling be added to the treatment plan, I would feel that my needs
are being respected”). Likewise, the credibility and expectancy subscales did not
require participants to have to choose between alternative physical and psychological
treatments. Statements in the credibility subscale were phrased in a way that precluded
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participants from having to choose one type of therapy over another (e.g., “How useful
do you think counseling would be in reducing your symptoms?”).
The strong effects held for the following motivation measures: MET-posttest,
Credibility, Expectancy - even after all possible covariates thought to influence
motivation (MET-pretest, type of consultation, counseling helpful, and part-time
employment) were examined. One exception was the effects for the FMP (OP)
subscale, which trended toward significance. This finding is not particularly surprising
since this scale addresses past and vicarious as well as future anticipation of therapy
(e.g., “One or more of my friends had good overall experience with psychological
treatment” or “In the past I have toyed with the idea of seeking out psychological
treatment”). In contrast, the MET-posttest; Credibility and Expectancy subscales
addressed current readiness (e.g., “I believe that whether my symptoms are caused by
physical or emotional reasons, I need to get help for both” or “If you were to go to
counseling or are in counseling now, how much improvement in your symptoms do
you think will occur by the end of counseling?”). Moreover, a substantial number of
participants declined to answer questions 8 and 42 on this scale, and the items were
subsequently deleted from the scale. The missing responses (although question 42 was
optional) could have contributed to the non significant result.
There may be other reasons why the FMP scales were unable to detect
differential effects between the two conditions in the final analysis. Subtle nuances or
differences inherent in European vs. United States language and culture could have
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influenced how participants in the current study interpreted and responded to the
wording of questions. The FMP has more routinely been used for comparing effects
of treatment over time. The instrument also has been used more often within a
therapeutic context rather than within medical consultation.
Additional regression analyses examining the relationships of the METpretest, counseling helpful, and type of condition with the motivation measures (METposttest, Credibility, and Expectancy), while controlling for the overall positive effect
towards counseling in the enhanced condition, found a significant interaction for the
enhanced consultation interview group and negative view of counseling. This finding
was significant for the MET-posttest motivation measure and trended towards
significance for the credibility subscale. Essentially, those with less favorable attitudes
about counseling who were assigned to the enhanced consultation interview were less
motivated to engage in therapy than those with more favorable attitudes towards
counseling. This suggests that negative feelings about counseling influenced
motivation to engage in therapy (on the MET-posttest motivation measure).
Although it may not be all that surprising and somewhat intuitive that those
who have had negative experiences with counseling would not likely be receptive to
counseling for what they perceive as a physical problem, a number of reasons for this
finding are considered. First, participants who had previous negative experiences
might develop negative expectations for future mental health treatment. Those who
had a bad experience may have consequently developed a negative bias towards
110

counseling and are unlikely to envision a positive one for any condition. Second, if
participants had a negative experience of counseling for what might have been a more
customary “psychological” issue, the suggestion that counseling would be offered in
connection with a “physical” condition may seem farfetched. Finally, those with
negative feelings about counseling might be reacting to stigma they perceived when
previously seeking help from a mental health provider. The risk may not feel worth it
to them.
It is also noteworthy that this finding was significant for the MET and not the
other measures. Perhaps the items composed in this newly developed measure were
sensitive enough to discern this difference between the two groups. Those with
unfavorable attitudes towards counseling, therefore, might benefit from additional
education about the nature, purpose and advantages of counseling. Having patients
complete a questionnaire to elicit information about past experiences with counseling
before the medical consultation might help to identify individuals who might not have
had an optimal counseling experience. Those with negative experiences could be
invited to share and process their perceptions about counseling with a therapist. This
initial step may facilitate an alternative view of counseling that would promote
patient's reconsideration of counseling as an adjunct to medical care for physical
symptoms. Part of this discussion would also include reassurance that medical care
would be provided regardless of the decision to enter therapy.
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Sociodemographic characteristics associated with motivation for
psychotherapy included participants who had higher education and prior counseling
(credibility) and current counseling (FMP (OP) subscales). This finding may suggest
that those with higher education and prior and current experience with counseling
perceive therapy as more reasonable and appropriate for reducing somatization
symptoms. Those with higher education may also have had more exposure to
information and resources regarding counseling, and those with prior counseling
experiences may have sufficient opportunities to assess its utility. While higher
education has been shown to be associated with higher motivation for therapy using
the FMP scales (Timmer, Bleichhardt, & Rief, 2006), the association between
previous therapy and motivation remains equivocal.
The MET-posttest measure demonstrated high internal consistency and
convergent validity with the other motivation scales. It was anticipated that this
measure would tap into underlying dimensions that other scales lacked. However, the
high correlation between the MET-posttest and the Credibility subscale suggest
potential overlap in the dimensions being measured. Further research on the METposttest and Credibility subscale measures may help to identify more precisely
whether unique dimensions are being examined.
Theory Integration
The theoretical constructs thought to be most important in forming the bases of
the enhanced consultation interview appear to have influenced the findings for this
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intervention. More specifically, these constructs help to explain how and why this
intervention may have worked. Although it is difficult to isolate which of the three
theories was more or less influential, an argument can be made that elements from all
three theories appeared integral to the process of motivating individuals to engage in
therapy along with their medical consultation. Dualism appears to be the one common
factor addressed by these three theories and its reduced impact may have helped to
enhance motivation for mental health therapy.
Cognitive dissonance.
Reconciliation of two opposing beliefs about oneself lies at the heart of
cognitive dissonance theory (Festinger & Carlsmith, 1959). There is a strong need to
reduce the stress caused by the imbalance. It is possible that the discourse of the
enhanced vignette preempted the internal conflict that would likely ensue if beliefs
about physical versus psychological nature of symptoms are challenged. The enhanced
vignette highlighted how symptoms could be either physical, psychological or both,
with one or the other type more prevalent at a given time. This vignette communicated
the message that patient's symptoms are acknowledged and accepted at face value
regardless of their underlying cause. This in effect removes the dispute over whether
symptoms are physical or psychological (dualism). Consequently, patients don’t have
to work to balance opposing beliefs about their symptoms. Without having to direct
their energy towards gaining acceptance of their perspective, patients may be freed up
to entertain and explore the potential benefits of therapy.
113

Attributions.
Attribution theory posits that people think and behave depending on their
interpretation and assignment of causes for experiences (Roesch & Weiner, 2001).
These attributions are described as polarities (e.g., positive versus negative, physical
versus psychological, controllable versus uncontrollable, stable versus unstable).
Extending this premise to physical complaints, attributions are made about diagnosis
and treatment. These attributions then guide decisions about coping and motivating
behaviors (Michela & Wood, 1986). Attention to these possible attributional styles
may have helped to obscure the dualistic position of assessment and treatment of
symptoms and thus enhanced motivation of patients to engage in therapeutic
treatment. For example, if patients are not locked into one or the other (physical vs.
psychological) interpretation of their symptoms, they may be more willing to explore
the benefits of counseling. The discourse of the enhanced consultation may help
patients to shift their understanding of psychological treatment from exploring deepseated emotional problems to the management of stress associated with their physical
symptoms. This form of consultation emphasized that symptoms can optimally be
treated but care must include the amelioration of stress that comes with physical
symptoms regardless of whether these symptoms are categorized as physical or
psychological. This is an optimistic position which subtly suggests to patients that
symptoms are manageable (e.g., polarity of controllable versus uncontrollable).
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Finally, the enhanced consultation interview addresses the polarity of stable versus
unstable by suggesting that symptoms can alternate between physical, emotional, or
both. The medical provider’s continued involvement and assessment implies that
physical symptoms are indeed fluid and can fluctuate. The medical provider will be
available to modify treatment as new information comes forward.
Expectancy.
Expectancy is another theory thought to have been impacted by the enhanced
consultation intervention. The interrelated propositions that form the basis of this
approach include strength of belief that action will lead to improved outcomes (e.g.,
“If I work at this, I will get better”) or “If I work at this, can I really reach my goal?”);
and how satisfied, valuable, convincing or attractive an outcome will be (e.g., “Is it
worth it?” or “Do I prefer this outcome over others?”). The medical provider discusses
with confidence that, in his or her experience, individuals with somatization and who
engage in mental health therapy can realize improvements in both physical and
emotional symptoms. The offering of combined physical and psychological support
in the enhanced interview addresses each of these expectancy propositions and also
averts the dualistic debate. This strategy may help to reduce stigma that often
accompanies the recommendation of (only) “psychological” treatment, thereby
making therapy a more attractive option (Valence). Patients can expect that the act of
going to counseling will not cause them to forfeit their relationship with their medical
practitioner. In fact, they benefit from having both types of professionals available to
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help address their symptoms. This can help minimize anxiety and, instead, invoke a
sense of confidence and security. Furthermore, the clarification of the intent of therapy
(to address stress caused by symptoms) may be more in line with patients’
expectations and more consistent with their ideas for realizing improvement.
In summary, the enhanced consultation interview emboldens the patient to
consider a more holistic approach to the symptoms they bring to the medical
practitioner. The particular discourse offered in this vignette allows patients to feel
respected, heard, and believed, without having to fight or defend the nature of, and
treatment options for, their symptoms. Finally, patients have a clear understanding of
the rationale and motive for the therapeutic process.
Strengths and Limitations
A strength of this study was its ability to addresses a serious a gap in the
literature regarding how providers can facilitate patient’s motivation for mental health
treatment. Much speculation has been offered about barriers and conditions that might
influence patient’s motivation for counseling during the medical consultation. Yet,
there has not heretofore been a study designed to test these elements against the more
typical consultation interview. An additional strength of this study was the
optimization of internal validity by using randomized assignment and adding a
covariate (MET-pretest) to statistically adjust for differences in the motivation
measures that might be a result from differences in the pre-existing groups. Also
contributing to the strength of this study was the development of the MET. Although it
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was informed by the other two measures of motivation for therapy, the MET added
elements thought to be unique to the study population. The MTF demonstrated high
internal consistency and was the most sensitive of the outcomes measures for
detecting differences between the conditions. Moreover, this instrument was able to
detect the interaction between negative counseling experiences and the enhanced
interview condition.
The rather robust findings in this study suggest that an analogue intervention
in written discourse has sufficient discriminative value to help detect aspects of
consultation that would motivate those with somatization to participate in therapy. The
current investigation provides support and direction for development of a more reallife portrayal of the consultation interview (face to face, actual intervention) to be
empirically tested in the future. It is conceivable that a more real life representation
might show even stronger differences. Requiring little time, training, and effort makes
this intervention adaptable and feasible to implement in private practice settings as
well as larger organizations.
Some of the limitations of this research involve practical issues such as the
costs required to conduct a study with a true probability sample. A convenience
sample (volunteers with medically unexplained physical symptoms) rather than a
randomly selected sample was used, which limits generalizability of the findings to
other populations. Convenience samples run the risks of self-selected participation for
reasons which could inadvertently bias results. The sample may have underrepresented
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those individuals with medically unexplained symptoms who did not speak English or
access the advertisements used to recruit participants. Additionally, the current
recession might have motivated some individuals to participate for reimbursement,
offering exaggerated, feigned or confabulated symptoms. Finally, the study included a
self-rating of medically unexplained physical symptoms without corroboration from a
medical provider. While recruiting a convenience sample was a strategic decision
based on the difficulty of obtaining a population-based sample of individuals with
somatization, the sampling approach makes it difficult to confirm unequivocally the
representativeness of the sample.
The cross-cultural application of the FMP may have posed a limitation by
inadvertently introducing a cultural bias into the instrument when it was translated
from German to English. This bias may have resulted in unintended alteration of
content that consequently distorted responses of the participants. Examination of the
FMP's internal consistency reliability and convergent validity provides some
reassurance that this problem did not occur.
The interrelatedness of three theories thought to influence motivation to
engage in mental health treatment makes it difficult to examine the extent to which
each contributes to variation in the scores for increased motivation. Future studies
might utilize comparative designs which could help prioritize the most essential
elements of the enhanced consultation interview that motivated patients to engage in
mental health. Along similar lines, a longitudinal design would be important to
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examine how motivation was sustained during therapy and how symptoms were
affected over several time points.
Finally, the participants were exposed to simulated rather than actual
interventions. Participants were asked to read a vignette, place themselves in the shoes
of the patient, and rate how motivated they would be to engage in mental health
treatment. This experience lacks the contextual information that might have resulted in
a different pattern of participation. Participants involved in an actual consultation
would have additional sensory input available during the discussion with their medical
provider. This sensory information, such as tone of voice, expression, posture, and
mannerisms, might impact patients’ motivation to participate in therapy. For example,
during the consultation, a patient notices that his or her provider gives very little eye
contact and speaks without much inflection in his or her voice. The patient might
perceive this provider to be disinterested, irritated, or blaming, which could affect how
the patient interprets the provider’s recommendation for therapy. The patient might
infer from such an interaction that the provider doesn’t believe the patient and is
offering therapy as a way to quickly end the consultation. The scenario just described
might deter a patient from engaging in therapy, especially if that patient was initially
opposed to mental health treatment.
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Implications
Practice Implications
While the findings from this study will need to be interpreted with caution,
they provide encouraging information to suggest that the enhanced consultation
approach can increase motivation for mental health therapy. These results have
practice implications for medical and mental health providers as well as patients.
Policy Implications.
The reattribution and collaborative care models have been put forth as ideal
approaches to treat patients with medically unexplained physical symptoms. Patientcentered communication forms the foundation of the reattribution model (Goldberg,
Gask, & O'Dowd, (1989). The primary elements include acknowledgment of patients’
physical symptoms, beliefs, and psychosocial stressors; extension of problem beyond
just the physical to consider the psychological; and facilitating the understanding of
how physical and psychological are connected and finally negotiating treatment. The
collaborative care model includes a five-step patient-centered process to cultivate a
positive relationship between medical provider and patient and three-stepped method
to educate and facilitate patient involvement in treatment (Smith, et al., 2003).
Referrals are made to other mental health therapists, if patients are considered likely to
benefit. Additionally, the medical provider incorporates some elements of CBT within
the medical consultation.
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While both of these medically-oriented models have demonstrated positive
outcomes with those who have medically unexplained physical symptoms, there are
several problems with these models, described in Chapter 2 that might be overcome
with the approach detailed in the current study. These include lack of comprehensive
treatment and improvement in both physical and emotional outcomes (Morris, et al.,
2007); onus on the medical provider to deliver the care and physician’s reluctance to
be trained in these models (Dowrick et al., 2008; Salmon et al., 2007); lack of cost
benefit (Luo et al., 2007); and lack of information related to the outcomes and
feasibility of these models in U.S. private practice clinics.
Medically-oriented models typically demand significant resources to both
teach and implement. Yet, these costs have not shown to be offset by benefits of these
treatment practices.
Perhaps most important, CBT has been well substantiated in several systematic
reviews as the only evidenced-based treatment for those with medically unexplained
physical symptoms (Sumathipala, 2007). CBT itself has the best track record for
success with these types of patients when offered by trained therapists. Yet, CBT
needs to be provided in concert with medical care to make it more acceptable to
patients as well as comprehensive. Instead of teaching physicians to do therapy,
perhaps it makes more sense to teach them to collaborate with mental health workers
and to learn fairly straightforward approaches, such as the method validated in this
study, for discussing the benefits of integrated treatment with patients. Education,
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specifically medical curricula, often helps to define what is important and valued in
professional roles (Salmon, 2007). It may be through this venue that acceptance is
achieved for medical consultation visits to endorse the use and benefit of mental health
therapy.
The findings from this study also help substantiate the need for dismantling of
current reimbursement practices for medical treatment. Funds that would more
typically be consumed by many health referrals, tests and intrusive procedures could
be diverted to enable medical providers to spend a little more time in the consultation
process addressing integrative health needs. In the long run, costs in health and mental
health care could be reduced. The passage of the Paul Wellstone Mental Health and
Addiction Equity Act, HR 1424, 2008) can be seen as a step in the right direction. By
creating more parity between mental health and physical health care coverage, it sends
the message that both are integral to care.
Implications for Medical Providers
The chief advantage of the approach validated in this study for medical
providers is having clear discussion points to integrate into consultation with patients
that would help motivate them for psychotherapy. This approach would require a
modest effort to learn and little time to incorporate in the consultation interview with
the patient. Feeling more confident about what elements to cover that would lead
patients toward therapy may make medical providers less likely to dismiss or eschew
patients with somatization. Medical providers also may feel a sense of relief to know
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that they don’t have to convince the patient of the inadequate evidence for the physical
origin of symptoms. Additionally, medical providers could be less constrained by their
own cognitive dissonance about having to fix something that may not be fixable with
physical medicine. They would also not be required to act as both the therapist and the
medical provider, a role that would undoubtedly require learning an additional set of
skills. Medical providers, in general, and physicians more specifically, have been
shown to be unwilling to be trained in models of care in which they must provide
psychological care over and above their medical training (Salmon et al., 2007).
Utilizing the method validated by the current study, medical providers could fully
employ their medical expertise to assess, monitor and care for the patient while
partnering with a mental health therapist who could provide the counseling. In this
way, the medical provider is not the sole treatment provider, but is supported by the
mental health provider who can help shoulder the responsibility for psychological care
and offer a more comprehensive treatment plan.
Implications for Mental Health Providers.
Mental health professionals and social workers specifically, are keenly adept at
recognizing, assessing and treating the biopsychosocial nuances that might come to
bear on a patient’s health and well being. Treatment improves when signs of stress,
coping and loss can be situated and understood in the context of the patient’s cultural,
social, economic, and religious experience. Furthermore, the expertise of mental
health counselors can help medical providers raise their awareness of these factors and
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the important role they play in the presentation of symptoms. Without social worker
involvement, these issues would likely go unnoticed or be dismissed, which could
result in suboptimal care. The medical provider can instead use this knowledge to
formulate a more customized and effective treatment plan for the patient.
An integrative treatment approach, if fostered at the onset of the medical
consultation, could help social workers commence work on more substantive issues
with the patient in a timelier fashion without having to first work through patient’s
reluctance to accept the merits of counseling. This joint approach also fosters the
importance and credibility of the mental health provider’s role in the treatment of
patients with unexplained symptoms. As medical providers come to appreciate the
therapeutic benefits of mental health counseling with these patients, it is conceivable
that more parity between the professions and perhaps more equitable insurance
reimbursement can ensue.
Implications for Patients.
Findings from this study advance the approach to care in which there is a
juxtaposition of medical and mental health professionals. This seems to result in the
most holistic, effective and acceptable treatment. Patients benefit from receiving the
expertise of each type of provider as well as the synergistic effects resulting from the
combination of providers. They receive quality medical care and quality mental health
care as well as the best evidenced based therapy (CBT) for medically unexplained
physical symptoms. Moreover, the provision of this combined approach from the
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onset helps to normalize the recommendation for mental health care since it is not
given as a last resort when providers don’t know what else to do. This normalization
of care further reduces the stigma of patients receiving “psychological” care for
physical symptoms. It becomes the standard for treatment rather than the exception.
This concept of “team” treatment approach has been in place for other medical settings
such as hospice where patients (and families) come to expect that disciplines will be
working together in order to best manage their symptoms. It is anticipated that the
perceptions of patients with somatization regarding joint care will be transformed from
a contrived exception to a natural step.
Future Directions.
This study provides a springboard for future research of patients with
medically unexplained symptoms. First, replication of this research with a real life
portrayal of the medical consultation (face-to-face intervention) could be conducted to
further substantiate the effects found in the analogue study. Second, a longitudinal
study might investigate the level of symptom improvement for those patients who
engaged in both physical and psychological treatment. Effects would be measured for
physical and emotional symptoms. Third, a study may explore the effects of this
consultation with other populations (e.g., depression, PTSD, anxiety). This research
would require slight modifications of the medical consultation method (e.g., replacing
the condition of physical symptoms with depression or PTSD). Forth, future studies
might explore the extent to which each of the three theories contribute to the variations
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of scores for increased motivation in order to prioritize the most critical elements that
should be integrated in medical consultation.

Conclusion
With such an intervention in hand, the medical provider can anticipate a more
comprehensive assessment and treatment with the additional view and support of the
counselor. The mental health provider can become a valuable and credible member of
the treatment team offering assessment and treatment from a wide lens perspective
which complements the physician’s efforts and acknowledges the patient’s
uniqueness. The patient will reap the benefits from a the combined medical and
psychological armamentarium which tackles the problem of medically unexplained
symptoms from many angles, including pain, physical functioning, relationships,
employment, finances, depression, anxiety, etc. An intervention of this nature has
potential to remove the proverbial debate of physical vs. emotional and the
concomitant stigma often associated with dualistic care. This holistic approach affords
the patient with expertise and support that can address the often interwoven
complexities of managing unexplained physical symptoms (See Appendix A. for
Somatization Model of Care).
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APPENDIX A. Somatization Model of Care

Patient
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Affecting Somatization
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Mind/body
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Appendix B Recruitment Flyer
DO YOU HAVE PHYSICAL SYMPTOMS THAT YOUR MEDICAL
PROVIDER CAN’T EXPLAIN?
If you do, you are invited to participate in a study
A study examining how providers can help patients deal with the stress of having
medically unexplained physical symptoms is being conducted in areas throughout
Oregon as part of a PhD dissertation at Portland State University.
You are invited to take part in this study if:
•
You have at least 2 medically unexplained physical symptoms for the last 6
months that your health provider hasn’t been able to explain;
•

You are between the ages of 18 and 65.

The study consists of completing questionnaires that will take approximately one
hour and will be conducted by email or regular mail.

You will receive $50 upon your return of the completed questionnaires.

If you think that you might be interested in the study, please contact
Terry Chianello at 541- 410-2274 or email me at tchianello@msn.com.
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Appendix C. Provider Letter
A study that will examine the relationship of patients with medically unexplained physical
symptoms and engagement in mental health treatment is being conducted throughout areas
of Oregon as part of my PhD dissertation in Social Research at Portland State University.
The treatment of those with medically unexplained physical symptoms can be difficult for
provider and patient. Systematic reviews of randomized controlled trials have demonstrated
that combined physical and mental health treatment can be optimal in reducing both physical
and psychological symptoms for many patients with medically unexplained physical
symptoms. Typically, it is the medical consultation where the discussion of optimal care
takes place. In spite of the solid efforts of respectful and caring medical practitioners to
motivate patients to consider psychological care along with medical care, many patients are
resistant to mental health treatment. Moreover, patients often feel offended, shamed and
blamed when the option of mental care treatment is raised. A series of untoward events can
ensue which include doctor shopping; extensive tests or procedures, and increased health
care costs. The result can leave both provider and patient with an unacceptable outcome.
The central aim of the study is to identify what essential elements need to be discussed
during the medical consultation that will encourage patients with medically unexplained
symptoms to engage in mental health therapy while under the care of their primary medical
provider. To date, there has not been a study that has systematically identified and
investigated these elements in the course of the medical consultation process. This will be an
analogue (simulated) study with participants randomized into one of two conditions:
enhanced medical consultation and care as usual condition.
Participation in this research may help patients begin to explore other approaches to address
their symptoms. Medical providers also may benefit from the findings of the study--a
discussion strategy to motivate patients to engage in mental health while preserving the
medical relationship.
I would very much appreciate the opportunity to discuss the possibility of posting the
enclosed flyers in your organization or practice. Your input regarding how best this would
work in your particular organization or practice is welcomed.
If you have any questions regarding the study, please contact me at (541) 410-2274.
Sincerely,

Terry Chianello, MSW, LCSW
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Appendix D Craigslist Advertisement
Reply to: event—Number @craigslist.org
Posting Title: Do you have physical symptoms that your health provider can’t
explain?

Posting Description: If you have unexplained symptoms, you are invited to
participate in a study
This study examines how health providers can help patients deal with the
stress of having managing medically unexplained physical symptoms. The
study will take place throughout Oregon. This research is being conducted as
part of a PhD dissertation at Portland State University.
You are invited to take part in this study if:
•

You have at least 2 medically unexplained physical symptoms for the
last 6 months that your health provider hasn’t been able to explain;

•

You are between the ages of 18 and 64.

The study consists of completing questionnaires that will take approximately
one hour and will be conducted by mail, email, or in person at a convenient
location and time.
Study participants receive $50.
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Appendix E. Advertisement for Newsletters and Magazines

A study examining how health providers can discuss integrative care with
patients having medically unexplained physical symptoms is being conducted in
areas throughout the Northwest as part of a PhD dissertation at Portland State
University.
You are invited to take part in this study if:
•
You have at least 2 medically unexplained physical symptoms for the last 6
months that your health provider hasn’t been able to explain;
•

You are between the ages of 18 and 65.

Study participants receive $50.

If you think that you might be interested in the study, please contact
Terry Chianello at 541- 410-2274 or email me at tchianello@msn.com.
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Appendix F. SOMS-7

Instruction:
A number of different bodily complaints are listed below.
Please indicate (by placing an “X” next to number) whether you have suffered from these symptoms within the past 7 days.
Consider only symptoms, for which no clear causes have been found by physicians, and which have affected your wellbeing.
I have read the instructions:

Yes

No

In the past 7 days, I suffered from the following complaints:
(1) Headaches
(2) Pain in the stomach
(3) Back pain
(4) Joint pain
(5) Pain in the legs and/ or arms
(6) Chest pain
(7) Pain in the anus
(8) Pain during sexual intercourse
(9) Pain during urination
(10) Nausea
(11) Bloating
(12) Stomach discomfort or churning feeling in the stomach

not at all
0
0
0
0
0
0
0
0
0
0
0
0

Degree of Impairment
mild
medium
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2

severe
3
3
3
3
3
3
3
3
3
3
3
3

very severe
4
4
4
4
4
4
4
4
4
4
4
4
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Instruction:
A number of different bodily complaints are listed below.
Please indicate (by placing an “X” next to number) whether you have suffered from these symptoms within the past 7 days.
Consider only symptoms, for which no clear causes have been found by physicians, and which have affected your wellbeing.
In the past 7 days, I suffered from the following complaints:
Degree of Impairment
not at all
(13) Vomiting (pregnancy excluded)
(14) Bringing swallowed food up again
(15) Hiccough, or burning sensations in chest or stomach
(16) Food intolerance
(17) Loss of appetite
(18) Bad taste in mouth, or excessively coated tongue
(19) Dry mouth
(20) Frequent diarrhea
(21) Discharge of fluids from anus
(22) Frequent urination
(23) Frequent bowel movements
(24) Strong heart pounding

0
0
0
0
0
0
0
0
0
0
0
0

mild
1
1
1
1
1
1
1
1
1
1
1
1

medium
2
2
2
2
2
2
2
2
2
2
2
2

severe
3
3
3
3
3
3
3
3
3
3
3
3

very severe
4
4
4
4
4
4
4
4
4
4
4
4
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Instruction:
A number of different bodily complaints are listed below.
Please indicate (by placing an “X” next to number) whether you have suffered from these symptoms
within the past 7 days.
Consider only symptoms, for which no clear causes have been found by physicians, and which have affected your wellbeing.
Degree of Impairment
In the past 7 days, I suffered from the following complaints:
not at all

mild

medium

severe

very severe

(25) Discomfort in the area around the heart
(26) Sweating (hot or cold)
(27) Flushing or blushing
(28) Breathlessness (without exertion)
(29) Painful breathing or hyperventilation
(30) Excessive tiredness or mild exertion
(31) Blotchiness or discoloration of the skin
(32) Sexual indifference (loss of libido)
(33) Unpleasant sensations in or around the genitals

0
0
0
0
0
0
0
0
0

1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3

4
4
4
4
4
4
4
4
4

⊗
(34) Impaired coordination or balance
(35) Paralysis or localized weakness
(36) Difficulty swallowing or lump in the throat
(37) Aphonia (loss of voice)

0
0
0
0

1
1
1
1

2
2
2
2

3
3
3
3

4
4
4
4
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Please indicate whether you have suffered from these symptoms within the past 7 days.
Consider only symptoms for which no clear causes have been found by physicians,
and which have affected your well-being.
Degree of Impairment
In the past 7 days, I suffered from the following complaints:
not at all

mild

medium

(38) Urinary retention
(39) Hallucinations
(40) Loss of touch or pain sensation
(41) Unpleasant numbness or tingling sensations
(42) Double vision
(43) Blindness
(44) Deafness
(45) Seizures
(46) Amnesia (loss of memory)
(47) Loss of consciousness

0
0
0
0
0
0
0
0
0
0

1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3
3

4
4
4
4
4
4
4
4
4
4

⊗
For women:
(48) Painful menstruation
(49) Irregular menstruation
(50) Excessive menstrual bleeding
(51) Continuous/ frequent vomiting during pregnancy
(52) Unusual or copious vaginal discharge

0
0
0
0
0

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

4
4
4
4
4

For men:
(53) Erectile or ejaculatory dysfunction

0

1

2

3

4
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severe

very severe

Appendix G.

DEMOGRAPHIC INFORMATION

1. What is your age? __________
2. Gender
Male______

Female_______ Other______

3. How many years of education have you have completed? (Count high school or
GED as 12) ___________
4. How do you describe yourself? (Please circle or place an “x” near the one option
that best describes you)
•
•
•
•
•
•
•

American Indian or Alaska Native
Hawaiian or Other Pacific Islander
Asian or Asian American
Black or African American
Hispanic or Latino
Non-Hispanic White
Other _______________

5. Marital status (put an x near the option that best describes you)
•
•
•
•
•
•
•

Married
Divorced
Widowed
Separated
Never been married
A member of an unmarried couple
Single

5. What is your employment status? (put an x near the option that best describes you)
• Working full-time
• Working part-time
• Unemployed
6. Are you disabled?
Yes_____
No______
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7. What is your household income? (put an x near the option that best describes you)
•
•
•
•
•
•

Less than $15,000 per year
$15,000 to < $25,000 per year
$25,000 to < $40,000 per year
$40,000 to < $70,000 per year
$70,000 to < $100,000 per year
$100,000 or more per year

8. Have you ever been in counseling before?
Yes__ No__
If yes, did your counselor suggest a diagnosis?
Yes___
No__
If yes, what was the diagnosis you received?
____________________________________________________________________
____________________________________________________________________
Did you find counseling helpful?
Yes___
No___
Are you currently in counseling?
Yes____
No___
9. Is there anything that you would like to hear from your doctor that might help you
feel better about getting help for
both physical and emotional care?
_____________________________________________________________________
___________________________________________________________________
10. If you wanted to add counseling to your medical treatment plan, would there be
anything getting in your way?
____________________________________________________________________
____________________________________________________________________

Thank you for completing this questionnaire!
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Appendix H. FMP
© 1989 Beitz Test GmbH, Göttingen
Beltz Test GmbH
Rohnsweg 25, D-37085 Gottingen, Germany
Tel: +49 (0)551 49609-0 Fax: -88
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Appendix I. Credibility/Expectancy Questionnaire
Based on the DISCUSSION YOU JUST READ (if your doctor talked to you this way),
place an “X” under the number that corresponds to the number which best describes
your response.
1. How logical would counseling offered to you seem?
Not at all logical
1
2
3

Somewhat logical
5
6

4

7

8

Very logical
9

2. How useful do you think counseling would be in reducing your
symptoms?
Not at all useful
1
2
3

Somewhat useful
5
6

4

7

8

Very useful
9

3. How confident would you be in recommending counseling to a friend who
experiences similar problems?
Not at all
1
2

3

4

Somewhat
5

Very
6

7

8

9

4. If you were to go to counseling or are in counseling now, how much
improvement in your symptoms do you think will occur by the end of
counseling?
None at all
1
2

3

4

5

6

7

Total Improvement
8
9

Please identify what you really feel about counseling and its likely success.
5. If you were to go to counseling, how much do you really feel that
counseling will help you to reduce your symptoms?
Not at all useful
1
2

3

4

Somewhat useful
5
6

7

8

Very useful
9

157

6. If you were to go to counseling, how much improvement in your symptoms
do you really feel will occur by
the end of counseling?
Not at all
1
2

3

Somewhat
4
5

6

7

Very much
8
9

Copyright. Grant J. Devilly & Thomas D. Borkovec
(2000 Elsevier Science Ltd. All rights reserved)
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Appendix J. MET PRETEST Please rate how strongly you agree with each of these statements.
Strongly
Disagree
1.

2.

3.

4.

The only way my physical symptoms
will get better is if I get help from a
medical provider.
If my doctor recommends that I go to
counseling for my physical symptoms,
it probably means that the doctor thinks
my symptoms are all my head.
I have a good understanding of how
counseling can help me.
I believe that whether my symptoms are
caused by physical or emotional
reasons, getting help for both makes
sense.

5. I wouldn’t go to counseling because the
process of finding a counselor is
difficult.
6. If my doctor recommended adding
counseling to my treatment plan, I
would feel that the doctor is looking for
a way to get rid of me.
7. If my doctor suggested adding
counseling to the treatment plan, I
would not feel that the doctor believes I
have a physical problem.
8. Counseling is just as important as
medical care for helping me cope with
my physical symptoms.
9.

Disagree

Neither
Agree nor
Disagree

Agree

Strongly
Agree

5

4

3

2

1

5
1

4
2

3
3

2
4

1
5

1

2

3

4

5

5

4

3

2

1

5

4

3

2

1

5

4

3

2

1

1

2

3

4

5

5

4

3

2

1

5

4

3

2

1

1

2

3

4

5

1

2

3

4

5

I worry that if I go to counseling, my
doctor will think that I don’t need
medical care.

10. If I went to counseling, it would mean
that my physical problems don’t really
exist.
11. If my doctor suggested that I go to
counseling, I would feel that my needs
are being respected.
12. I would be more likely to go to
counseling if it was available in the
same building as my doctor.
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Appendix K. MET POSTTEST. Based on the DISSCUSION YOU JUST READ, please rate how
Strongly you agree with each of these statements. (Place an x in the box)
Strongly
Disagree
1.

2.

3.

4.

The only way my physical symptoms
will get better is if I get help from a
medical provider.
If my doctor recommends that I go to
counseling for my physical symptoms,
it probably means that the doctor thinks
my symptoms are all my head.
I have a good understanding of how
counseling can help me.
I believe that whether my symptoms are
caused by physical or emotional
reasons, getting help for both makes
sense.

5. I wouldn’t go to counseling because the
process of finding a counselor is
difficult.
6. If my doctor recommended adding
counseling to my treatment plan, I
would feel that the doctor is looking for
a way to get rid of me.
7. If my doctor suggested adding
counseling to the treatment plan, I
would not feel that the doctor believes I
have a physical problem.
8. Counseling is just as important as
medical care for helping me cope with
my physical symptoms.
9.

Disagree

Neither
Agree nor
Disagree

Agree

Strongly
Agree

5

4

3

2

1

5
1

4
2

3
3

2
4

1
5

1

2

3

4

5

5

4

3

2

1

5

4

3

2

1

5

4

3

2

1

1

2

3

4

5

5

4

3

2

1

5

4

3

2

1

1

2

3

4

5

1

2

3

4

5

I worry that if I go to counseling, my
doctor will think that I don’t need
medical care.

10. If I went to counseling, it would mean
that my physical problems don’t really
exist.
11. If my doctor suggested that I go to
counseling, I would feel that my needs
are being respected.
12. I would be more likely to go to
counseling if it was available in the
same building as my doctor.

160

Appendix L. Expert Panel Ratings of the Enhanced and Care as Usual Vignettes
Please rate the following statements using the 5-point Likert Scale
1.

Strong
Disagree
1

Does this vignette reflect typical responses of a medical provider to a patient with medically
unexplained physical symptoms?
Disagree
2

Neither
Agree nor Disagree
3

Agree

Strongly Agree
4

5

2. Is the possibility of mixed etiology (physical and emotional) communicated?
Strong
Disagree
Neither
Agree
Strongly Agree
Disagree
Agree nor Disagree
1
2
3
4

5

3.

Does the provider communicate the message that he/she will still be involved if the patient goes to
counseling?
Strong
Disagree
Neither
Agree
Strongly Agree
Disagree
Agree nor Disagree
1
2
3
4
5

4. Did the provider convey belief in the patient’s symptoms?
Strong
Disagree
1

Disagree
2

Neither
Agree nor Disagree
3

Agree

Strongly Agree
4

5

5. Does the provider imply that the symptoms may be in the patient’s head?
Strong
Disagree
Neither
Agree
Strongly Agree
Disagree
Agree nor Disagree
1
2
3
4

5
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Appendix M.

DISCUSSION

(a)

PLEASE READ THE FOLLOWING CONVERSATION BETWEEN A
MEDICAL PROVIDER AND A PATIENT
(Refer to this discussion to respond to the next 3 questionnaires)

Provider

Good morning. How are you feeling today?

Patient

Not good. My pain has been really acting up again. I am getting so tired
of it.

Patient

I was hoping that the tests and workup we did last time would tell me
how to get rid of this pain. It has me worried that something is really
wrong and no one is able to find out what it is.

Provider

We have completed the medical history and physical. We also ran tests
we thought might help to pinpoint what is causing your pain. However,
the tests we ran didn’t help us figure out what is wrong.

Provider

Why don’t you give me an update about your pain?

Patient

Well my pain is still in my legs and arms and back. I notice it
practically all the time.

Provider

What do you think is causing your pain?

Patient

I am not sure, it might be my joints, or a disease they haven’t found yet.

Provider

Do you think stress or emotional problems might be causing your
pain?

Patient

I am not any more stressed than usual. And, I don’t have any
psychological problems that I know of.

Provider

Are you depressed or anxious?

Patient

Well, my pain doesn’t let me do the things I want, like gardening and
other chores—even fun things like going out with friends, walks, etc. I
feel upset when I can’t do these things. It really gets in the way of my
sleep too.
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Provider

It sounds like your pain is still causing you a lot of problems. How are
you dealing with it?

Patient

I just grin and bear it. Not much else I can do. I put up with it, I have no
choice. It would sure help to know what is causing my pain.

Patient

There must be something that can be done.

Provider

The tests don’t point to any disease or cause of your physical pain.

Provider

Many patients worry about having an illness that no one has figured out
and feel they need to have more tests or more visits with their doctor.

Patient

Well, I am not ready to give up and am not sure that you have done all
the necessary tests. Perhaps we haven’t looked hard enough.

Provider

At this point, we have run all the tests necessary to get to the bottom of
your pain, and we haven’t found anything that can help us identify what
is wrong.

Patient

So, what are you saying?

Provider

I am not sure how to help you.

Provider

I wish I could help you but there isn’t anything else I can do.

Patient

Are you trying to tell me that you no longer to need to see me?

Provider

Well, there isn’t much left for me to do. I can suggest that you go to
counseling. My office staff has some information on counselors in the
area.
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Appendix N.

DISCUSSION (b)

PLEASE READ THE FOLLOWING CONVERSATION BETWEEN A
MEDICAL PROVIDER AND A PATIENT
(Refer to this discussion to respond to the next 3 questionnaires)
Provider

Good morning. How are you feeling today?

Patient

Not good. My pain has been really acting up again. I am getting so tired
of it.

Patient

I was hoping that the tests and work up we did last time would tell me
how to get rid of this pain. It has me worried that something is really
wrong and no one is able to find out what it is.

Provider

The tests we ran didn’t help us figure out what is wrong. Why don’t
you give me an update about your pain?

Patient

Well my pain is still in my legs and arms and back. I notice it
practically all the time.

Provider

What are your thoughts on what might be causing your pain?

Patient

I am not sure, it might be my joints, or a disease they haven’t found yet.

Provider

It must be frustrating –especially since the tests we have done have not
told us what is wrong.

Provider

I am wondering how your pain is affecting your life?

Provider

Pain can sometimes lead to other problems for people such as stress.
Stress can add to pain and really get in the way of managing the
problem. Sometimes people feel depressed or anxious. Has that
happened for you?

Patient

Well if you mean that my pain doesn’t let me do the things I want, like
gardening and other chores—even fun things like going out with
friends, walks, etc. then yeah, it is causing me stress. I feel upset when I
can’t do these things. It really gets in the way of my sleep too.
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Provider

It sounds like your pain has caused a lot of problems. That makes a lot
of sense. I can see how this would bother anyone. How do you manage
the stress that your pain has caused?

Patient

I just grin and bear it. Not much else I can do. I put up with it, I have no
choice.

Patient

So what do we do next?

Provider

Provider

I would hope that we can identify what is causing your pain and then be
able to treat it. We could run a few more tests, but I am worried that
the tests won’t reveal anything that can help us figure out what is
wrong.
Sometimes physical symptoms remain unexplained.

Patient

You mean that there might not be a diagnosis for symptoms like mine?

Provider

Symptoms such as yours-- generalized pain, tension, fatigue, poor sleep
can remain unexplained. I want you to know that I believe that you
have physical symptoms. However, sometimes, we really don’t know
what is causing the pain. The cause of pain can fluctuate. At times it
can be all physical, sometimes times it can emotional or sometimes a
little of both. But, regardless of “cause” of the symptoms, most
patients who have pain that can’t be explained can become stressed.

But a good treatment plan really needs to tackle the physical pain and any accompanying
emotional stress. Counseling is something that I have found very helpful in situations
where we might not know or find out exactly what is causing your pain. I want to be
clear that counseling is not a substitute for medical care; it is an addition to the
medical support that I will provide. The counselor‘s job is to help you deal with any
stress that is associated with your physical symptoms, not to look for a psychological
cause of your pain. A counselor can be your sounding board, offer ideas, strategies and
discuss anything else that may be bothering you. You and I will continue to work
closely with each other to monitor and address your physical symptoms. I mention the
idea of adding a counselor to our treatment plan now-just in case the few tests we have
left doesn’t tell us anything. How does the idea of adding a counselor to our treatment
plan sound to you? I could have you meet the counselor whose office is right down the
hall from me.
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Appendix O.

Telephone Script

Participant has called / emailed and communicated interest.
Researcher

“Hello, this is Terry Chianello, I am the PhD student who is conducting
the study on medically unexplained physical symptoms.” Is this an OK
time to talk about a study?

If no, Is there a better time to call?

If person gives a better time of day to call again, researcher will note person's

preference and call back.

If yes, continue with the following.
Researcher: “I am calling to see if you are still interested in hearing more about the
study?
If no,
Researcher: “Thank you for your time.”
If yes,
Researcher “Great. I appreciate your interest. This is a study that examines how
health providers can help patients deal with the stress of having
medically unexplained physical symptoms. Those who are eligible for
the study need to have at least 2 medically unexplained physical
symptoms for the last 6 months. If you would like to learn more, I can
read you the consent form.
If yes,
Researcher:

Reads the consent and answers any questions. “Now that you have
heard the consent and had any questions answered, do you still want to
participate?”

If no,
Researcher: “Thank you for your time.”
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If yes,
Researcher records individual's name and date on consent record. Finally, researcher
asks the participant if they would like a copy of the results once the study is completed.
If yes, the researcher records the participant's contact information to send the findings
on a separate sheet, which does not include study ID number.

Researcher:
Participant:

Researcher:

If yes,
Researcher:

Participant :
Researcher:

“Thank you. Let’s begin. Can you tell me your medically unexplained
physical symptoms are and how long you have had them?”
_______________________________________________________

“Are you actively being treated for other diagnoses such as Cancer,
Diabetes, or any other health problems that would cause your physical
symptoms?

“I am sorry that I cannot include you in the study since your symptoms
may be due to an illness for which you are actively being treated or
“participants must have at least 2 symptoms to be included in the study.
Thank you for your time.”
If No,
OK, now that we've determined you are eligible for the study,“I have 12
questions to ask you. Each question is rated on a 5 point scale –from
strongly disagree to strongly agree. I will read the statement and I
would like you to tell me how much you agree with it.”

Once completed…..
Researcher:

“Thank you for completing the first part of the study. How would you
prefer to complete the second portion of the study?”

In person: Which location, date and time ______________________________
By mail: Address:_________________________________________________
Email:__________________________________________________________
Researcher:

“Thank you so much. You will be receiving the second part of the
study this week” (depending on the preference of the participant,
mail or email).
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Appendix P.

PARTICIPANT CONSENT
in STUDY of
Medically Unexplained Physical Symptoms and
Engagement in Mental Health Therapy

Principal Investigator
Terry Chianello, PhD student in the School of Social Work at Portland State
University. Telephone: 541-410-2274.

Why have I been asked to take part in this research study?
You have been invited to take part in this study because you have had at least two
medically unexplained physical symptoms for the last 6 months.
Who is conducting the study?
I am conducting this study as a PhD student at Portland State University, where
my supervisor is Dr. Laurie Powers. To graduate with a doctoral degree, I have to
complete a research project approved by Portland State University.
Why is this research study being done?
You are being asked to take part in this study to help medical providers learn how
to help patients deal with the stress of having unexplained physical symptoms.
How many people will take part in the study?
About 150 people will be in the study.
What will happen if I take part in this research study?
You will be asked a few questions to be sure that you can be in the study. If you
can take part, you will first ask you to answer 12 short questions. Then you will be
sent some other questionnaires that will take you about 1 hour to finish. You can
get these questionnaires by email, regular mail, or arrange to do them in person at
a convenient location and time. After you’re done completing these
questionnaires, you can return them to me in a pre-stamped envelope or in person.
How long will I be in the study?
You will be done with the study when you return the questionnaires to me.
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Can I stop being in the study?
You do not have to take part in this study, and if you start and later change your
mind, you may quit at any time. If you stop this study, it will not affect your
relationship with your doctors or with other medical providers.
Can anyone else stop me from being in the study? (The local hospital IRB is
requesting that I include this statement)
Since your participation is confidential, no one else except my supervisor and me
will know that you took part in the study. Therefore, only you and us can stop you
from being in the study.
What side effects or risks can I expect from being in the study?
You may find that some of the questions seem personal or completing the
questionnaires might make you tired.
How will I be protected from any risks?
If you do become upset by taking part in this study, you will be given a resource
information sheet that includes mental health hotlines. If you want additional help,
I will contact a mental health worker or call a crisis hotline on your behalf.
Are there benefits to taking part in this study?
Your participation in the study may improve what we know of how people
understand and cope with the emotions of medically unexplained physical
symptoms.
What other choices do I have if I do not take part in this study?
If you to not take part in this study, you can continue on your own to seek care for
the symptoms you have been having. I am not aware of similar studies for you.
Will my answers be kept private?
To protect your confidentiality, any information you provide for this study will be
kept private. The questionnaires given for you to complete will have code numbers
instead of your name. The information you provide will be kept in a locked file
and will only be available to my and my supervisor. These materials will be
destroyed in about one year after the study is over.
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What are the costs of taking part in this study?
To thank you for being in this study, I will give you $50 for completing the
questionnaires and returning them to me.
How will I learn the results of the study?
The study will be done in about 8 months. I will send you the results of the study
unless you tell me that you are not interested.
Consent obtained for participant to receive results of study by Terry Chianello via
telephone
Date:

Name of Participant

Do any of doctors who will be taking care of me have a personal financial
(monetary) interest in this study that may affect how they treat me?
Neither my supervisor nor I have personal financial interests or reasons to do this
study.
Where can I get more information?
If you have concerns or problems about being in this study or your rights as a
research participant, please contact the Human Subjects Research Review
Committee, Office of Research and Sponsored Projects, Portland State University,
(503) 725-4288 / 1-877-480-4400. You may also contact Dr. Laurie Powers at
503-725-9605. If you have questions about the study, contact Terry Chianello at
541-410-2274.

Thank you for your interest in this study.

Printed Name of Subject

Terry Chianello, Principal Investigator

Date of Consent
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Appendix Q.

INSTRUCTION SHEET

Thank you for your interest in participating in the study on how medical providers can
help patients deal with the stress of medically unexplained physical symptoms. Your
participation will help to improve our understanding of individuals with medically
unexplained physical symptoms.
Below is a step-by-step guide to complete the rest of the study. Please follow the steps
in the order listed. If you have any questions, please contact me at 541-410-2274 or
by email at tchianello@msn.com.
Step 1.

Please complete DOCUMENT #1, the pink titled sheet (SOMS7)

Step 2.

Please read DOCUMENT # 2 the blue titled sheet (Discussion)
and base your responses to the next 3 questionnaires on this
discussion.

Step 3.

Please complete DOCUMENT #3, the green titled questionnaire
(12-item posttest)

Step 4.

Please complete DOCUMENT #4, the purple titled
questionnaire (Credibility/Expectancy)

Step 5.

Please complete DOCUMENT #5, the red titled questionnaire
(FMP)

Step 6.

Please complete DOCUMENT # 6, the gray titled questionnaire
(Demographic)

Step 7.

For those receiving and completing these materials by mail,
please enclose all the documents above in the self-stamped
envelope and mail to me.
For those receiving materials by email, first save the
documents to a file. Mark your responses. Save the
documents, then attach them in an email and send them back to
me.

As soon as I receive these materials, I will send you a check for $50 by mail. If you
are completing these materials in person, you will be given the check at that time.
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Appendix R. Resource Information Sheet
RESOURCE INFORMATION SHEET

Deschutes County
Scott Johnson, Director
Deschutes County Mental Health Dept.
2577 NE Courtney Drive
Bend, OR 97701
Information: 541-322-7500
Crisis Line: 1-888-232-7192
FAX: 541-322-7565
TTY: 541-322-7610
Crook County
Crook County Mental Health Program
Lutheran Community Services
203 NE Court
Prineville, OR 97754
Information: 541-447-7441
Crisis Line: 1-888-232-7192
FAX: 541-447-6694 (Courthouse, City Hall)
TTY: 1-800-735-2900 (O.R.S.)
Jefferson County
Best Care Treatment Services
Crisis Line: 1-888-232-7192
FAX: 541-475-6196
TTY: 1-800-735-2900 (O.R.S.)
St. Charles Medical Center
2500 NE Neff Road
Bend, Oregon
541 389-7160

IF YOU NEED IMMEDIATE HELP, CALL 911
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Appendix S. Thank you note

Dear Participant,

I would like to thank you for your participation in the study investigating the
emotional aspects of managing medically unexplained medical symptoms.
Enclosed you will find a check for $50.
Your participation is highly valued and will help us improve our understanding of
individuals with medically unexplained physical symptoms.

Sincerely,

Terry Chianello
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